{"content":"<li class=\"n-box-item date-title\" data-end=\"1559879999\" data-start=\"1559793600\" data-txt=\"Monday, December 23, 2019\">Thursday, June  6, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3469727\" data-ts=\"1559860255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469727-vertex-pharmaplus-4_3-on-exonics-acquisition-crispr-rises-on-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vertex Pharma +4.3% on Exonics acquisition; Crispr rises on deal</a></h4><ul>   <li>Vertex Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>) is <font color=\"green\">up 4.3%</font> after hours following the announcement that it's expanding gene editing capabilities by <a href=\"https://seekingalpha.com/pr/17537690-vertex-expands-new-disease-areas-enhances-gene-editing-capabilities-expanded-collaboration\" target=\"_blank\">acquiring Exonics Therapeutics</a> and entering a licensing deal with Crispr Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a>).</li>    <li>Crispr is <font color=\"green\">up 10.9%</font> after hours.</li>    <li>Vertex will acquire privately held Exonics for an upfront payment of $245M along with potential milestone payments.</li>    <li>Meanwhile, Vertex will pay $175M upfront for exclusive worldwide rights to Crispr's \"existing and future intellectual property including foundational CRISPR/Cas9 technology, novel endonucleases, single and double cut guide RNAs, and AAV vectors for DMD and DM1 gene editing products.\"</li>    <li>The moves enhance Vertex's capability to develop novel therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1, the company says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469727\" data-linked=\"Vertex Pharma +4.3% on Exonics acquisition; Crispr rises on deal\" data-tweet=\"$VRTX $CRSP - Vertex Pharma +4.3% on Exonics acquisition; Crispr rises on deal https://seekingalpha.com/news/3469727-vertex-pharmaplus-4_3-on-exonics-acquisition-crispr-rises-on-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3469727-vertex-pharmaplus-4_3-on-exonics-acquisition-crispr-rises-on-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469722\" data-ts=\"1559858981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTHR\" target=\"_blank\">CTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469722-charles-colvard-files-for-equity-offering-sharesminus-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charles &amp; Colvard files for equity offering; shares -16%</a></h4><ul>   <li>Charles &amp; Colvard (NASDAQ:<a href='https://seekingalpha.com/symbol/CTHR' title='Charles & Colvard, Ltd.'>CTHR</a>) has filed a <a href=\"https://seekingalpha.com/filing/4523714\" target=\"_blank\">prospectus to offer shares</a> through Roth Capital Partners.</li>    <li>The size of the offering is yet undetermined.</li>    <li>Proceeds will go to marketing and for general purposes.</li>    <li>Earlier, the company <a href=\"https://seekingalpha.com/news/3469708-charles-and-colvard-16-percent-q419-fy-guidance\" target=\"_blank\">offered Q4 and fiscal 2019 net sales guidance</a> and said it would report results in early September.</li>    <li>Shares are now <font color=\"red\">down 15.8%</font> after hours.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469722\" data-linked=\"Charles &amp; Colvard files for equity offering; shares -16%\" data-tweet=\"$CTHR - Charles &amp; Colvard files for equity offering; shares -16% https://seekingalpha.com/news/3469722-charles-colvard-files-for-equity-offering-sharesminus-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3469722-charles-colvard-files-for-equity-offering-sharesminus-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469716\" data-ts=\"1559857694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469716-docu-bynd-crsp-and-ges-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOCU, BYND, CRSP and GES among notable after hour movers</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color=\"green\">+17.3%</font>. <a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a> <font color=\"green\">+14.3%</font>. <a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics AG'>CRSP</a> <font color=\"green\">+8.5%</font>. <a href='https://seekingalpha.com/symbol/ELGX' title='Endologix, Inc.'>ELGX</a> <font color=\"green\">+4%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a> <font color=\"red\">-20.5%</font>. <a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a> <font color=\"red\">-18.1%</font>. <a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings, Inc.'>OLLI</a> <font color=\"red\">-3.1%</font>. <a href='https://seekingalpha.com/symbol/GES' title='Guess&#39;, Inc.'>GES</a> <font color=\"red\">-1.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469716\" data-linked=\"DOCU, BYND, CRSP and GES among notable after hour movers\" data-tweet=\"$ZUMZ $BYND $ZM - DOCU, BYND, CRSP and GES among notable after hour movers https://seekingalpha.com/news/3469716-docu-bynd-crsp-and-ges-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469716-docu-bynd-crsp-and-ges-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469708\" data-ts=\"1559855968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTHR\" target=\"_blank\">CTHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469708-charles-colvard-down-16-on-q419-and-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charles &amp; Colvard down 16% on Q419 and FY guidance</a></h4><ul><li>Charles &amp; Colvard (NASDAQ:<a href='https://seekingalpha.com/symbol/CTHR' title='Charles & Colvard, Ltd.'>CTHR</a>) <a href=\"https://seekingalpha.com/pr/17537659-charles-and-colvard-provides-fourth-fiscal-quarter-2019-full-year-financial-guidance\" target=\"_blank\">expects</a> net sales for its Q4 and full-year fiscal 2019 to be in the range of $7.0 - $7.2M ($6.4M prior) and $31.6 to $31.8M, respectively.</li><li>Shares <font color=\"red\">-16% AH</font>.</li><li><a href=\"https://seekingalpha.com/pr/17537659-charles-and-colvard-provides-fourth-fiscal-quarter-2019-full-year-financial-guidance\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3469708\" data-linked=\"Charles &amp; Colvard down 16% on Q419 and FY guidance\" data-tweet=\"$CTHR - Charles &amp; Colvard down 16% on Q419 and FY guidance https://seekingalpha.com/news/3469708-charles-colvard-down-16-on-q419-and-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3469708-charles-colvard-down-16-on-q419-and-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469699\" data-ts=\"1559854726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PD\" target=\"_blank\">PD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469699-pagerdutyplus-5-on-upside-fy20-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pagerduty +5% on upside FY20 outlook</a></h4><ul><li>Pagerduty (NYSE:<a href='https://seekingalpha.com/symbol/PD' title='PagerDuty, Inc.'>PD</a>) <font color=\"green\">gains 5%</font> after its first earnings print after the IPO. PD <a href=\"https://seekingalpha.com/news/3469672-pagerduty-eps-beats-0_02-beats-revenue\" target=\"_blank\">beat Q1 estimates </a>with a 49% Y/Y revenue growth.</li><li>The Q2 outlook has upside revenue of $38.5-$39.5M (consensus: $37.12M) and in-line loss per share of $0.10 to $0.09 (consensus: $0.10 loss).</li><li>The upside FY20 view has revenue of $161-163M and loss per share of $0.38 to $0.37.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Finvestor.pagerduty.com&amp;esheet=51994569&amp;newsitemid=20190606005812&amp;lan=en-US&amp;anchor=investor.pagerduty.com&amp;index=2&amp;md5=d1eb69a5ea8b323548436ef9e089c2fa\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17537588-pagerduty-announces-first-quarter-fiscal-year-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469699\" data-linked=\"Pagerduty +5% on upside FY20 outlook\" data-tweet=\"$PD - Pagerduty +5% on upside FY20 outlook https://seekingalpha.com/news/3469699-pagerdutyplus-5-on-upside-fy20-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3469699-pagerdutyplus-5-on-upside-fy20-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469696\" data-ts=\"1559854325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOMO\" target=\"_blank\">DOMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469696-domominus-18_9-on-downside-q2-revenue-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domo -18.9% on downside Q2 revenue view</a></h4><ul><li>Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) craters <font color=\"red\">18.9%</font> after the <a href=\"https://seekingalpha.com/news/3469660-domo-eps-beats-0_20-beats-revenue\" target=\"_blank\">Q1 results</a> were washed away by a downside Q2 revenue forecast of $41-42M (estimate: $42.3M) with an in-line loss per share of $1.02 to $0.98 (estimate: $1.00 loss).</li><li>The FY20 view has a narrower than expected loss per share of $3.87 to $3.79 (estimate: $4.02 loss) and in-line revenue of $173-174M (estimate: $173.9M).</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://www.globenewswire.com/Tracker?data=lL3i36ycxTXxVLCwymZJSsfvopZlkEof5N-s4ck4Wp3KnvRCHr_VgtRBTArah7sARfL_Wds1bPpXqngxM-UAS7foDRG9XgURcNrwUYUbEAY=\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17537572-domo-announces-fiscal-2020-first-quarter-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469696\" data-linked=\"Domo -18.9% on downside Q2 revenue view\" data-tweet=\"$DOMO - Domo -18.9% on downside Q2 revenue view https://seekingalpha.com/news/3469696-domominus-18_9-on-downside-q2-revenue-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3469696-domominus-18_9-on-downside-q2-revenue-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469695\" data-ts=\"1559854173\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469695-guessplus-4-after-americas-segment-shines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess +4% after Americas segment shines</a></h4><ul><li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess&#39;, Inc.'>GES</a>) trades <font color=\"green\">4.05% higher</font> in AH trading after matching estimates with its Q1 report.</li><li>Results in the Americas segment impressed, with retail comparable sales up 4% and operating margin up 230 bps compared to a year ago.</li><li>\"During the quarter we were also able to complete a convertible debt transaction at very favorable terms to deploy funds to buy back company shares,\" notes CEO Carlos Alberini.</li><li>Looking ahead, Guess anticipates FY20 revenue growth of +3.5% to +4.5% vs. +4% to +5% prior view and EPS of $1.19 to $1.30 vs. $1.18 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469670-guess-eps-beats-0_01-revenue-line\" target=\"_blank\">Guess EPS beats by $0.01,  revenue in-line</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469695\" data-linked=\"Guess +4% after Americas segment shines\" data-tweet=\"$GES - Guess +4% after Americas segment shines https://seekingalpha.com/news/3469695-guessplus-4-after-americas-segment-shines?source=tweet\" data-url=\"https://seekingalpha.com/news/3469695-guessplus-4-after-americas-segment-shines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469693\" data-ts=\"1559853823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZM\" target=\"_blank\">ZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469693-zoomplus-10_8-on-upside-full-year-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoom +10.8% on upside full-year outlook</a></h4><ul><li>Zoom Video (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>)<font color=\"green\"> soars 10.8%</font> on its first post-IPO print. The <a href=\"https://seekingalpha.com/news/3469674-zoom-video-communications-eps-beats-0_02-beats-revenue\" target=\"_blank\">Q1 results</a> beat estimates with 103% Y/Y revenue growth.</li><li>The Q2 view has upside revenue of $129-130M (estimate: $122.3M) and in-line EPS of $0.01 to $0.02 (estimate: $0.01).</li><li>Upside FY guidance has revenue of $535-540M (estimate: $522.2M) and EPS of $0.02 to $0.03 (estimate: $0.01).</li><li>The number of customers contributing more than $100K in the trailing 12 months grew 120% Y/Y to 405.</li><li>Earnings call starts at 5 PM ET with a webcast <a href=\"https://investors.zoom.us/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17537600-zoom-video-communications-reports-first-quarter-results-fiscal-year-2020\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469693\" data-linked=\"Zoom +10.8% on upside full-year outlook\" data-tweet=\"$ZM - Zoom +10.8% on upside full-year outlook https://seekingalpha.com/news/3469693-zoomplus-10_8-on-upside-full-year-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3469693-zoomplus-10_8-on-upside-full-year-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469692\" data-ts=\"1559853704\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SB\" target=\"_blank\">SB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469692-safe-bulkers-unveils-stock-buyback-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Safe Bulkers unveils stock buyback plan</a></h4><ul><li>Safe Bulkers (NYSE:<a href='https://seekingalpha.com/symbol/SB' title='Safe Bulkers, Inc.'>SB</a>) <font color=\"green\">+9.1%</font> after-hours on news it authorized a <a href=\"https://seekingalpha.com/pr/17537566-safe-bulkers-inc-announces-common-stock-repurchase-program\" target=\"_blank\">5M-share repurchase program</a>.</li><li>SB says the program would represent 4.9% of the shares of its common stock outstanding and 9.7% of its public float if the maximum number of shares are  purchased.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469692\" data-linked=\"Safe Bulkers unveils stock buyback plan\" data-tweet=\"$SB - Safe Bulkers unveils stock buyback plan https://seekingalpha.com/news/3469692-safe-bulkers-unveils-stock-buyback-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3469692-safe-bulkers-unveils-stock-buyback-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469689\" data-ts=\"1559853378\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLLI\" target=\"_blank\">OLLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469689-ollies-bargain-outlet-holdingsminus-2-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ollie&#39;s Bargain Outlet Holdings -2% after earnings</a></h4><ul><li>Ollie's Bargain Outlet Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings, Inc.'>OLLI</a>) reports comparable sales rose 0.8% in Q1 to fall short of the consensus estimate +1.5%.</li><li>Gross margin was 40.9% of sales vs. 40.9% a year ago.</li><li>Adjusted operating income fell 70 bps to 12.4% of sales as a result of the deleveraging of Ollie's pre-opening expenses.</li><li>The Company opened 21 stores during the quarter, ending the period with a total of 324 stores in 23 states (+17.4% Y/Y).</li><li>Looking ahead, Ollie's sees FY20 revenue of $1.44B to $1.453B vs. $1.45B consensus and EPS $2.13 to $2.17 vs. $2.15 consensus.</li><li>OLLI <font color=\"red\">-1.55%</font> AH to $96.05.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469666-ollies-bargain-outlet-eps-beats-0_02-beats-revenue\" target=\"_blank\">Ollie's Bargain Outlet EPS beats by $0.02, beats on revenue</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469689\" data-linked=\"Ollie&#39;s Bargain Outlet Holdings -2% after earnings\" data-tweet=\"$OLLI - Ollie&#39;s Bargain Outlet Holdings -2% after earnings https://seekingalpha.com/news/3469689-ollies-bargain-outlet-holdingsminus-2-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3469689-ollies-bargain-outlet-holdingsminus-2-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469685\" data-ts=\"1559852802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOCU\" target=\"_blank\">DOCU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469685-docusignminus-16-on-subscription-deceleration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DocuSign -16% on subscription deceleration</a></h4><ul><li>DocuSign (NASDAQ:<a href='https://seekingalpha.com/symbol/DOCU' title='DocuSign, Inc.'>DOCU</a>) <font color=\"red\">plunges 16%</font> after the <a href=\"https://seekingalpha.com/news/3469659-docusign-eps-beats-0_02-beats-revenue\" target=\"_blank\">Q1 beats</a> arrived with signs of slight subscription deceleration.</li><li>In-line Q2 guidance that has $218-222M in revenue (estimate: $219.9M) and billings of $215-225M.</li><li>The upside FY20 outlook has $917-922M (estimate: $913.65M) and billings of $1.01-1.03B.</li><li>In Q1, subscription revenue was up 36% Y/Y to $201.5M, down from the 37% growth in Q4, while professional services gained 64% to $12.5M. Billings totaled $215M, up 27%.</li><li>The adjusted gross margin was 79%, down one percentage point from last year's quarter. The subscription margin was flat on the year at 86%.</li><li>Cash from operating activities came in at $45.7M compared to the $15M last year. FCF was $30.4M versus $8.8M.</li><li>Earnings call starts at 4:30 PM ET with a webcast <a href=\"http://docusign.com/investors\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17537553-docusign-announces-first-quarter-fiscal-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469685\" data-linked=\"DocuSign -16% on subscription deceleration\" data-tweet=\"$DOCU - DocuSign -16% on subscription deceleration https://seekingalpha.com/news/3469685-docusignminus-16-on-subscription-deceleration?source=tweet\" data-url=\"https://seekingalpha.com/news/3469685-docusignminus-16-on-subscription-deceleration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469679\" data-ts=\"1559852584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XERS\" target=\"_blank\">XERS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469679-fda-extends-action-date-90-days-for-xeris-pharmas-glucagon-rescue-pen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA extends action date 90 days for Xeris Pharma&#39;s glucagon rescue pen</a></h4><ul><li>The FDA has <a href=\"https://seekingalpha.com/pr/17537573-xeris-pharmaceuticals-receives-notification-pdufa-date-extension-gvoke\" target=\"_blank\">extended its action date</a> to September 10 for its review of Xeris Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/XERS' title='Xeris Pharmaceuticals, Inc.'>XERS</a>) marking application for Gvoke (ready-to-use glucagon injection) for the treatment of severe hypoglycemia (low blood sugar).</li><li>The 90-day extension is standard operating procedure for the agency when there is a major amendment to an NDA. In this case, additional information requested by the review team constituted such an amendment.</li><li>Management will host a conference call today at 5:00 pm ET to discuss the situation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469679\" data-linked=\"FDA extends action date 90 days for Xeris Pharma&#39;s glucagon rescue pen\" data-tweet=\"$XERS - FDA extends action date 90 days for Xeris Pharma&#39;s glucagon rescue pen https://seekingalpha.com/news/3469679-fda-extends-action-date-90-days-for-xeris-pharmas-glucagon-rescue-pen?source=tweet\" data-url=\"https://seekingalpha.com/news/3469679-fda-extends-action-date-90-days-for-xeris-pharmas-glucagon-rescue-pen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469678\" data-ts=\"1559852488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469678-beyond-meat-rallies-after-first-post-ipo-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat rallies after first post-IPO earnings report</a></h4><ul><li>Shares of Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) are <font color=\"green\">up 5.10%</font> in AH trading after the plant-based meat producer reports sales growth of 215% in <a href=\"https://seekingalpha.com/pr/17537576-beyond-meat-reports-first-quarter-2019-financial-results\" target=\"_blank\">Q1</a>.</li><li>An adjusted EBITDA loss of $2.1M was reported for the quarter vs. -$4.3M a year ago.</li><li>Gross profit was 26.8% of sales vs. 16.1% a year ago.</li><li>Looking ahead, Beyond Meat expects FY19 revenue to $210M and for adjusted EBITDA to break even.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469661-beyond-meat-eps-beats-0_01-beats-revenue\" target=\"_blank\">Beyond Meat EPS beats by $0.01, beats on revenue</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469678\" data-linked=\"Beyond Meat rallies after first post-IPO earnings report\" data-tweet=\"$BYND - Beyond Meat rallies after first post-IPO earnings report https://seekingalpha.com/news/3469678-beyond-meat-rallies-after-first-post-ipo-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3469678-beyond-meat-rallies-after-first-post-ipo-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469674\" data-ts=\"1559852282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZM\" target=\"_blank\">ZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469674-zoom-video-communications-eps-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoom Video Communications EPS beats by $0.02, beats on revenue</a></h4><ul><li>Zoom Video Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>): Q1 Non-GAAP EPS of $0.03 <font color=\"green\">beats by $0.02</font>; GAAP EPS of $0.00 <font color=\"green\">beats by $0.02</font>.</li><li>Revenue of $121.99M (+103.1% Y/Y) <font color=\"green\">beats by $10.36M</font>.</li><li>Shares <font color=\"green\">+5.6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17537600-zoom-video-communications-reports-first-quarter-results-fiscal-year-2020\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3469674\" data-linked=\"Zoom Video Communications EPS beats by $0.02, beats on revenue\" data-tweet=\"$ZM - Zoom Video Communications EPS beats by $0.02, beats on revenue https://seekingalpha.com/news/3469674-zoom-video-communications-eps-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3469674-zoom-video-communications-eps-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469670\" data-ts=\"1559852245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GES\" target=\"_blank\">GES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469670-guess-eps-beats-0_01-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guess EPS beats by $0.01,  revenue in-line</a></h4><ul><li>Guess (NYSE:<a href='https://seekingalpha.com/symbol/GES' title='Guess&#39;, Inc.'>GES</a>): Q1 Non-GAAP EPS of -$0.25 <font color=\"green\">beats by $0.01</font>; GAAP EPS of -$0.27 <font color=\"red\">misses by $0.01</font>.</li><li>Revenue of $536.69M (+3.0% Y/Y) in-line.</li><li>Shares <font color=\"green\">+2.68%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17537587-guess-inc-reports-first-quarter-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3469670\" data-linked=\"Guess EPS beats by $0.01,  revenue in-line\" data-tweet=\"$GES - Guess EPS beats by $0.01, revenue in-line https://seekingalpha.com/news/3469670-guess-eps-beats-0_01-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3469670-guess-eps-beats-0_01-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469664\" data-ts=\"1559851929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTN\" target=\"_blank\">MTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469664-vail-resortsplus-2-after-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vail Resorts +2% after profit beat</a></h4><ul><li>Vail Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MTN' title='Vail Resorts, Inc.'>MTN</a>) reports total lift revenue increased 16.4% in Q1, driven by a 14.3% growth in skier visitation primarily from Triple Peaks and Stevens Pass.</li><li>Mountain reported EBITDA was up 14.4% during the quarter, primarily due to strong North American pass sales growth for the 2018/2019 North American ski season.</li><li>Looking ahead, Vail is now expecting resort reported EBITDA for the full fiscal year to be between $700M to $710M.</li><li>Shares of Vail are <font color=\"green\">up 1.71%</font> in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469658-vail-resorts-eps-beats-0_04-revenue-line\" target=\"_blank\">Vail Resorts EPS beats by $0.04,  revenue in-line</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469664\" data-linked=\"Vail Resorts +2% after profit beat\" data-tweet=\"$MTN - Vail Resorts +2% after profit beat https://seekingalpha.com/news/3469664-vail-resortsplus-2-after-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3469664-vail-resortsplus-2-after-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469661\" data-ts=\"1559851767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469661-beyond-meat-eps-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beyond Meat EPS beats by $0.01, beats on revenue</a></h4><ul><li>Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>): Q1 Non-GAAP EPS of -$0.14 <font color=\"green\">beats by $0.01</font>; GAAP EPS of -$0.95 <font color=\"red\">misses by $0.80</font>.</li><li>Revenue of $40.21M (+214.6% Y/Y) <font color=\"green\">beats by $1.28M</font>.</li><li>Shares <font color=\"green\">+4.91%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17537576-beyond-meat-reports-first-quarter-2019-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3469661\" data-linked=\"Beyond Meat EPS beats by $0.01, beats on revenue\" data-tweet=\"$BYND - Beyond Meat EPS beats by $0.01, beats on revenue https://seekingalpha.com/news/3469661-beyond-meat-eps-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3469661-beyond-meat-eps-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>157&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469654\" data-ts=\"1559851061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469654-worst-is-over-for-top-u-s-refiners-goldman-says-in-valero-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The worst is over for top U.S. refiners, Goldman says in Valero upgrade</a></h4><ul><li>Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a> <font color='green'>+2%</font>) is <a href=\"https://www.barrons.com/articles/bristol-myers-stock-celgene-pharmaceutical-rush-investors-merger-51559740060\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $96 price target at Goldman Sachs, as analyst Neil Mehta sees an opportunity to buy into higher quality U.S. refiners at a discount after the group pulled back ~10% in the past month.</li><li>Mehta sees underappreciated value in the renewable diesel segment given the focus on emissions reductions globally, and thinks VLO is positively leveraged to the IMO's 2020 emissions reduction rules.</li><li>VLO also should benefit from increased flows of crude to the U.S. Gulf Coast, where much of VLO's refining capacity is located, and Mehta finds the stock's valuation compelling at current levels, with a dividend yield approaching 5% and projected free cash flow yield of 10% through next year.</li><li>Mehta also likes Marathon Petroleum (<a href='https://seekingalpha.com/symbol/MPC' title='Marathon Petroleum Corporation'>MPC</a> <font color='green'>+0.9%</font>) - which is on Goldman's Conviction Buy List - as well as Buy-rated Phillips 66 (<a href='https://seekingalpha.com/symbol/PSX' title='Phillips 66'>PSX</a> <font color='green'>+0.4%</font>) and Par Pacific (<a href='https://seekingalpha.com/symbol/PARR' title='Par Pacific Holdings, Inc.'>PARR</a> <font color='red'>-0.6%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3469654\" data-linked=\"The worst is over for top U.S. refiners, Goldman says in Valero upgrade\" data-tweet=\"$VLO $MPC $PSX - The worst is over for top U.S. refiners, Goldman says in Valero upgrade https://seekingalpha.com/news/3469654-worst-is-over-for-top-u-s-refiners-goldman-says-in-valero-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3469654-worst-is-over-for-top-u-s-refiners-goldman-says-in-valero-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469650\" data-ts=\"1559849122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469650-easy-earnings-topper-37-revenue-rise-lift-saic-to-ytd-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Easy earnings topper, 37% revenue rise, lift SAIC to YTD high</a></h4><ul><li>Science Applications International (<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a> <font color=\"green\">+6.4%</font>) surges to its highest level since  September after handily beating <a href=\"https://seekingalpha.com/news/3469434-science-applications-eps-beats-0_15-revenue-line\" target=\"_blank\">Q1 earnings</a> estimates on in-line revenues, which jumped 37% Y/Y to $1.62B.</li><li>Excluding acquired revenues, the total fell by 2.8% in the quarter, attributable to humanitarian relief materials in the prior-year quarter and the affect of acquisition-related revenue dis-synergies.</li><li>SAIC says Q1 contract awards totaled $1B and net bookings came in at $1.4B, with 70% of the net bookings for new business; estimated backlog of signed business orders at quarter-end was ~$13.6B.</li><li>SAIC reaffirms its FY 2020 outlook, including its free cash flow target of $425M, although given the strength of its Q1 performance, the company believes it can meet or exceed the goal for the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469650\" data-linked=\"Easy earnings topper, 37% revenue rise, lift SAIC to YTD high\" data-tweet=\"$SAIC - Easy earnings topper, 37% revenue rise, lift SAIC to YTD high https://seekingalpha.com/news/3469650-easy-earnings-topper-37-revenue-rise-lift-saic-to-ytd-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3469650-easy-earnings-topper-37-revenue-rise-lift-saic-to-ytd-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469649\" data-ts=\"1559849116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EWW\" target=\"_blank\">EWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469649-progress-on-mexico-boosts-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress on Mexico boosts stocks</a></h4><ul><li>The <a href=\"https://www.washingtonpost.com/\" target=\"_blank\">Washington Post reports on</a> the beginnings of a possible agreement in which National Guard troops would be deployed along the Guatemalan border to halt migrants looking to move north.</li><li>The news has given an afternoon lift to the previously flat averages, with the S&amp;P 500 <font color=\"green\">up 0.7%</font> and Nasdaq <font color=\"green\">up 0.6%</font>.</li><li>The iShares Mexico ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>) remains <font color=\"red\">0.7% lower</font> for the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469649\" data-linked=\"Progress on Mexico boosts stocks\" data-tweet=\"$EWW - Progress on Mexico boosts stocks https://seekingalpha.com/news/3469649-progress-on-mexico-boosts-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3469649-progress-on-mexico-boosts-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469645\" data-ts=\"1559848852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEZS\" target=\"_blank\">AEZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469645-aeterna-zentaris-to-downsize-german-staff-shares-down-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aeterna Zentaris to downsize German staff; shares down 7%</a></h4><ul><li>Citing its aim to right-size its operations in Frankfurt, Germany to better reflect the size of the business there, Aeterna Zentaris (<a href='https://seekingalpha.com/symbol/AEZS' title='Aeterna Zentaris Inc.'>AEZS</a> <font color=\"red\">-7.4%</font>) will <a href=\"https://seekingalpha.com/pr/17537445-aeterna-zentaris-provides-corporate-update\" target=\"_blank\">terminate </a>eight positions. The company expects to pay ~$800K in severance costs by January 31, 2020, connected to the move.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469645\" data-linked=\"Aeterna Zentaris to downsize German staff; shares down 7%\" data-tweet=\"$AEZS - Aeterna Zentaris to downsize German staff; shares down 7% https://seekingalpha.com/news/3469645-aeterna-zentaris-to-downsize-german-staff-shares-down-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3469645-aeterna-zentaris-to-downsize-german-staff-shares-down-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469644\" data-ts=\"1559848771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469644-barnes-noble-seen-going-private-for-476m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble seen going private for $476M</a></h4><ul><li>Elliott Management is close to striking a deal to pay $6.50 per share for Barnes &amp; Noble, sources tell <em>Financial Times</em>. That deal price would value the retailer at $476M.</li><li>Shares of BKS are <font color=\"green\">up 31.6%</font> to $6.05 after trading at a 52-week low of $4.11 earlier in the session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469631-barnes-and-noble-spikes-wsj-report-sale\" target=\"_blank\">Barnes &amp; Noble spikes on WSJ report of sale</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469644\" data-linked=\"Barnes &amp; Noble seen going private for $476M\" data-tweet=\"Barnes &amp; Noble seen going private for $476M https://seekingalpha.com/news/3469644-barnes-noble-seen-going-private-for-476m?source=tweet\" data-url=\"https://seekingalpha.com/news/3469644-barnes-noble-seen-going-private-for-476m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469643\" data-ts=\"1559848113\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469643-cien-cmtl-and-cldr-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIEN, CMTL and CLDR among notable tech movers</a></h4><ul><li><strong>Gainers: </strong>Ciena Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"green\">+25%</font>. Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) <font color=\"green\">+17%</font>. Orion Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a>) <font color=\"green\">+16%</font>. Ideanomics (NASDAQ:<a href='https://seekingalpha.com/symbol/IDEX' title='Ideanomics, Inc.'>IDEX</a>) <font color=\"green\">+12%</font>. IDT Corporation (NYSE:<a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a>) <font color=\"green\">+11%</font>.</li> <li><strong>Losers: </strong>Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <font color=\"red\">-40%</font>. Vislink Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/VISL' title='Vislink Technologies, Inc.'>VISL</a>) <font color=\"red\">-18%</font>. Gravity (NASDAQ:<a href='https://seekingalpha.com/symbol/GRVY' title='Gravity Co., Ltd.'>GRVY</a>) <font color=\"red\">-18%</font>. TuanChe (NASDAQ:<a href='https://seekingalpha.com/symbol/TC' title='TuanChe Limited'>TC</a>) <font color=\"red\">-15%</font>. Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469643\" data-linked=\"CIEN, CMTL and CLDR among notable tech movers\" data-tweet=\"$CIEN $CMTL $OESX - CIEN, CMTL and CLDR among notable tech movers https://seekingalpha.com/news/3469643-cien-cmtl-and-cldr-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469643-cien-cmtl-and-cldr-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469634\" data-ts=\"1559845309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469634-selling-pressure-on-blue-apron-doesnt-relent\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selling pressure on Blue Apron doesn&#39;t relent</a></h4><ul> <li>Blue Apron (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) is <font color=\"red\">down 3.11%</font> on the day and traded at a 52-week low of $0.63 earlier in the session.</li> <li>The sell-side community has whiffed on Blue Apron but still has a consensus <a href=\"https://seekingalpha.com/symbol/APRN/ratings/sell-side-ratings\" target=\"_blank\">Hold rating</a> on Blue Apron (8 ratings), while the two Seeking Alpha Authors with articles on Blue Apron have been on the right side of the trade at Very Bearish.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3469634\" data-linked=\"Selling pressure on Blue Apron doesn&#39;t relent\" data-tweet=\"$APRN - Selling pressure on Blue Apron doesn&#39;t relent https://seekingalpha.com/news/3469634-selling-pressure-on-blue-apron-doesnt-relent?source=tweet\" data-url=\"https://seekingalpha.com/news/3469634-selling-pressure-on-blue-apron-doesnt-relent\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469633\" data-ts=\"1559845093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLEX\" target=\"_blank\">LLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469633-lilis-energy-chairman-ceo-ormand-retires-daches-named-interim-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilis Energy Chairman/CEO Ormand retires; Daches named interim CEO</a></h4><ul><li>Lilis Energy (<a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='red'>-8.2%</font>) is lower after naming President and CFO Joe Daches as <a href=\"https://seekingalpha.com/pr/17536384-lilis-energy-announces-appointment-david-m-wood-chairman-upon-retirement-ron-ormand-ceo\" target=\"_blank\">interim CEO</a> with the retirement of Chairman and CEO Ron Ormand, effective today, and selects David Wood as its new board chairman.</li><li>Ormand became Lilis CEO in April 2018 and was a co-founder and senior executive at Magnum Hunter Resources, highlighting 34 years of experience as a senior executive and investment banker in  the energy sector.</li><li>Daches joined Lilis in 2016  and became Executive VP, CFO and Treasurer in early 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469633\" data-linked=\"Lilis Energy Chairman/CEO Ormand retires; Daches named interim CEO\" data-tweet=\"$LLEX - Lilis Energy Chairman/CEO Ormand retires; Daches named interim CEO https://seekingalpha.com/news/3469633-lilis-energy-chairman-ceo-ormand-retires-daches-named-interim-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3469633-lilis-energy-chairman-ceo-ormand-retires-daches-named-interim-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469632\" data-ts=\"1559844801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOP\" target=\"_blank\">SHOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469632-shopify-gets-target-boost-on-over-hyped-competition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shopify gets target boost on &#39;over-hyped&#39; competition</a></h4><ul><li>KeyBanc raises its Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify Inc.'>SHOP</a>) target from $275 to $300, matching the Street-high target. The rating stays at Buy.</li><li>The bank cites \"over-hyped\" concerns about competition from Magento, which Adobe (<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Inc.'>ADBE</a> <font color='green'>+0.3%</font>) acquired last year. Analyst Josh Beck says the market has room for both companies.</li><li>Beck sees a path for Magento to gain a 9% share while Shopify picks up 2% with minimal overlap.</li><li>Upcoming catalyst: Shopify's Unite conference takes place June 18-20.</li><li>Shopify shares are <font color=\"green\">up 1.9%</font> to $298.15.</li><li>Shopify has an Outperform average <a href=\"https://seekingalpha.com/symbol/SHOP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469632\" data-linked=\"Shopify gets target boost on &#39;over-hyped&#39; competition\" data-tweet=\"$SHOP $SHOP $ADBE - Shopify gets target boost on &#39;over-hyped&#39; competition https://seekingalpha.com/news/3469632-shopify-gets-target-boost-on-over-hyped-competition?source=tweet\" data-url=\"https://seekingalpha.com/news/3469632-shopify-gets-target-boost-on-over-hyped-competition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469631\" data-ts=\"1559844227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469631-barnes-noble-spikes-on-wsj-report-of-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble spikes on WSJ report of sale</a></h4><ul><li>Trading in Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble, Inc.'>BKS</a> <font color='green'>+19.2%</font>) has been halted after volatility spiked following a Wall Street Journal <a href=\"https://www.wsj.com/articles/elliott-management-is-lead-bidder-in-auction-of-barnes-noble-11559843348\" target=\"_blank\">report</a> indicating that a sale of the retailer to Elliott Management is imminent.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469631\" data-linked=\"Barnes &amp; Noble spikes on WSJ report of sale\" data-tweet=\"$BKS - Barnes &amp; Noble spikes on WSJ report of sale https://seekingalpha.com/news/3469631-barnes-noble-spikes-on-wsj-report-of-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3469631-barnes-noble-spikes-on-wsj-report-of-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469629\" data-ts=\"1559843916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469629-only-u-s-gold-in-energy-materials-gainers-mammoth-energy-services-and-key-energy-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Only U.S. Gold in Energy/Materials gainers; Mammoth Energy Services and Key Energy Services among losers</a></h4><ul><li><b>Gainers:</b> U.S. Gold (NASDAQ:<a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a>) <font color=\"green\">+10%</font>.</li><li><b>Losers:</b> Mammoth Energy Services (NASDAQ:<a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services, Inc.'>TUSK</a>) <font color=\"red\">-38%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-10%</font>. Profire Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a>) <font color=\"red\">-7%</font>.Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"red\">-7%</font>.Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469629\" data-linked=\"Only U.S. Gold in Energy/Materials gainers; Mammoth Energy Services and Key Energy Services among losers\" data-tweet=\"$USAU $TUSK $KEG - Only U.S. Gold in Energy/Materials gainers; Mammoth Energy Services and Key Energy Services among losers https://seekingalpha.com/news/3469629-only-u-s-gold-in-energy-materials-gainers-mammoth-energy-services-and-key-energy-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3469629-only-u-s-gold-in-energy-materials-gainers-mammoth-energy-services-and-key-energy-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469627\" data-ts=\"1559843410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469627-snapplus-5_2-pivotal-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap +5.2% as Pivotal upgrades to Buy</a></h4><ul>   <li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) has moved up to its highest point since last July, <font color=\"green\">up 5.2%</font>, following an upgrade to Buy at Pivotal Research.</li>    <li>The firm boosted from a previous Hold rating and raised its price target to $17.25 from $13.25, now implying 27% upside.</li>    <li>That would make it an even half-dozen firms at a Buy-equivalent rating, vs. a few dozen at Hold and another half-dozen at Sell.</li>   <li>And that makes the average <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/sell-side-ratings\" target=\"_blank\">sell-side rating a Hold</a>, while <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/quant-ratings\" target=\"_blank\">Quant ratings match that at Neutral</a> and <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha authors are Bearish overall</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469627\" data-linked=\"Snap +5.2% as Pivotal upgrades to Buy\" data-tweet=\"$SNAP - Snap +5.2% as Pivotal upgrades to Buy https://seekingalpha.com/news/3469627-snapplus-5_2-pivotal-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3469627-snapplus-5_2-pivotal-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469620\" data-ts=\"1559841532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469620-american-superconductor-and-hovnanian-enterprises-among-industrial-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Superconductor and Hovnanian Enterprises among industrial losers</a></h4><ul><li><b>Gainers: </b>None</li><li><b>Losers: </b>MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-26%</font>. American Superconductor (NASDAQ:<a href='https://seekingalpha.com/symbol/AMSC' title='American Superconductor Corporation'>AMSC</a>) <font color=\"red\">-17%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">-11%</font>. Aqua Metals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals, Inc.'>AQMS</a>) <font color=\"red\">-8%</font>. Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469620\" data-linked=\"American Superconductor and Hovnanian Enterprises among industrial losers\" data-tweet=\"$MICT $AMSC $HOV - American Superconductor and Hovnanian Enterprises among industrial losers https://seekingalpha.com/news/3469620-american-superconductor-and-hovnanian-enterprises-among-industrial-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469620-american-superconductor-and-hovnanian-enterprises-among-industrial-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469615\" data-ts=\"1559840273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469615-provident-bancorp-leads-financial-gainers-hexindai-and-x-financial-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Provident Bancorp leads financial gainers, Hexindai and X Financial among losers</a></h4><ul><li><b>Gainers:</b> Provident Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/PVBC' title='Provident Bancorp, Inc.'>PVBC</a>) <font color=\"green\">+14%</font>. ATIF Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIF' title='ATIF Holdings Limited'>ATIF</a>) <font color=\"green\">+10%</font>. Carver Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a>) <font color=\"green\">+6%</font>. Mmtec (NASDAQ:<a href='https://seekingalpha.com/symbol/MTC' title='Mmtec, Inc.'>MTC</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Mr. Cooper Group (NASDAQ:<a href='https://seekingalpha.com/symbol/COOP' title='Mr. Cooper Group Inc.'>COOP</a>) <font color=\"red\">-7%</font>. Ashford Hospitality Trust (NYSE:<a href='https://seekingalpha.com/symbol/AHT' title='Ashford Hospitality Trust, Inc.'>AHT</a>) <font color=\"red\">-7%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"red\">-6%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"red\">-6%</font>. X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469615\" data-linked=\"Provident Bancorp leads financial gainers, Hexindai and X Financial among losers\" data-tweet=\"$PVBC $ATIF $CARV - Provident Bancorp leads financial gainers, Hexindai and X Financial among losers https://seekingalpha.com/news/3469615-provident-bancorp-leads-financial-gainers-hexindai-and-x-financial-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469615-provident-bancorp-leads-financial-gainers-hexindai-and-x-financial-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469612\" data-ts=\"1559839518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469612-cien-sfix-home-and-cldr-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIEN, SFIX, HOME and CLDR among midday movers</a></h4><ul><li><strong>Gainers: </strong>La Jolla Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Company'>LJPC</a>) <font color=\"green\">+87%</font>. ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"green\">+74%</font>. Ciena Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"green\">+24%</font>. Cidara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics, Inc.'>CDTX</a>) <font color=\"green\">+21%</font>. Dynatronics Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a>) <font color=\"green\">+16%</font>. Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) <font color=\"green\">+15%</font>. Eloxx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ELOX' title='Eloxx Pharmaceuticals, Inc.'>ELOX</a>) <font color=\"green\">+15%</font>. Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) <font color=\"green\">+15%</font>. OncoSec Medical Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCS' title='OncoSec Medical Incorporated'>ONCS</a>) <font color=\"green\">+15%</font>. Orion Energy Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a>) <font color=\"green\">+14%</font>.</li> <li><strong>Losers: </strong>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"red\">-54%</font>. At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) <font color=\"red\">-50%</font>. Kirkland's (NASDAQ:<a href='https://seekingalpha.com/symbol/KIRK' title='Kirkland&#39;s, Inc.'>KIRK</a>) <font color=\"red\">-47%</font>. Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"red\">-45%</font>. Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <font color=\"red\">-42%</font>. Mammoth Energy Services (NASDAQ:<a href='https://seekingalpha.com/symbol/TUSK' title='Mammoth Energy Services, Inc.'>TUSK</a>) <font color=\"red\">-36%</font>. Benitec Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec Biopharma Limited'>BNTC</a>) <font color=\"red\">-35%</font>. MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-28%</font>. Xeris Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XERS' title='Xeris Pharmaceuticals, Inc.'>XERS</a>) <font color=\"red\">-24%</font>. ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"red\">-22%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469612\" data-linked=\"CIEN, SFIX, HOME and CLDR among midday movers\" data-tweet=\"$LJPC $HEPA $CIEN - CIEN, SFIX, HOME and CLDR among midday movers https://seekingalpha.com/news/3469612-cien-sfix-home-and-cldr-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469612-cien-sfix-home-and-cldr-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469606\" data-ts=\"1559838406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469606-sentiment-sours-again-on-barnes-noble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sentiment sours again on Barnes &amp; Noble</a></h4><ul> <li>Barnes &amp; Noble (NYSE:<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble, Inc.'>BKS</a>) is <font color=\"red\">down 7.42%</font> and trades just pennies above the 52-week low a day after retailer GameStop went into a post-earnings nosedive.</li> <li>On Seeking Alpha, author Max Greve <a href=\"https://seekingalpha.com/article/4268526-barnes-and-noble-balance-sheet-bust-true-book-value-may-1\" target=\"_blank\">warned</a> yesterday that the true book value on BKS may be below $1. Meanwhile on Wall Street, only two firms provide coverage on the bookstore chain, with both sitting on Buy-equivalent ratings.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3469606\" data-linked=\"Sentiment sours again on Barnes &amp; Noble\" data-tweet=\"$BKS - Sentiment sours again on Barnes &amp; Noble https://seekingalpha.com/news/3469606-sentiment-sours-again-on-barnes-noble?source=tweet\" data-url=\"https://seekingalpha.com/news/3469606-sentiment-sours-again-on-barnes-noble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469604\" data-ts=\"1559837923\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRNT\" target=\"_blank\">VRNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469604-verint-holder-drops-proxy-fight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verint holder drops proxy fight</a></h4><ul><li>Verint Systems (<a href='https://seekingalpha.com/symbol/VRNT' title='Verint Systems Inc.'>VRNT</a> <font color='red'>-0.7%</font>)<a href=\"https://seekingalpha.com/pr/17537257-verint-neuberger-berman-announce-resolution-proxy-contest\" target=\"_blank\"> says</a> Neuberger Berman Investment Advisers has agreed to withdraw its three board nominees.</li><li>The decision follows \"constructive discussions,\" and the holder recommends other stockholders to vote for Verint's nominees.</li><li>Verint still plans to refinance its convertible notes and doesn't plan to settle them with shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469604\" data-linked=\"Verint holder drops proxy fight\" data-tweet=\"$VRNT - Verint holder drops proxy fight https://seekingalpha.com/news/3469604-verint-holder-drops-proxy-fight?source=tweet\" data-url=\"https://seekingalpha.com/news/3469604-verint-holder-drops-proxy-fight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469602\" data-ts=\"1559837673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469602-stock-markets-mixed-trade-weighs-against-ecb-moves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stock markets mixed as trade weighs against ECB moves</a></h4><ul><li>All three major U.S. stock averages take a noon dip, bringing the Nasdaq (<font color=\"red\">-0.1%</font>) into the red.</li><li>The S&amp;P 500 (<font color=\"green\">+0.1%</font>) and the Dow (<font color=\"green\">+0.2%</font>) manage to stay in positive territory.</li><li>Investors remain wary as optimism over looser monetary policy, reaffirmed by the ECB's Mario Draghi today, is counterbalanced by trade worries.</li><li>Energy (<font color=\"green\">+1.0%</font>) and consumer staples (<font color=\"green\">+0.5%</font>) outperform the broader market, as industrials (<font color=\"red\">-0.6%</font>) and real estate (<font color=\"red\">-0.3%</font>) lag.</li><li>Treasurys resume their rally, pushing the 10-year yield down almost 3 basis points to 2.095%.</li><li>Crude oil<font color=\"red\"> falls 0.4%</font> to $51.47 per barrel; gold <font color=\"green\">rises 0.7% </font>to $1,342.80 per ounce.</li><li>The Dollar Index <font color=\"red\">weakens 0.5%</font> to 96.88.</li><li>The euro<font color=\"green\"> rises 0.6% </font>against the dollar after ECB President Draghi said the central bank will act to sustain expansion in the Euro-zone.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469602\" data-linked=\"Stock markets mixed as trade weighs against ECB moves\" data-tweet=\"Stock markets mixed as trade weighs against ECB moves https://seekingalpha.com/news/3469602-stock-markets-mixed-trade-weighs-against-ecb-moves?source=tweet\" data-url=\"https://seekingalpha.com/news/3469602-stock-markets-mixed-trade-weighs-against-ecb-moves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469599\" data-ts=\"1559836879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469599-tesla-and-workhorse-group-in-consumer-gainers-amira-nature-foods-and-la-z-boy-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla and Workhorse Group in consumer gainers; Amira Nature Foods and La-Z-Boy among losers</a></h4><ul><li><b>Gainers: </b>Workhorse Group (NASDAQ:<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a>) <font color=\"green\">+13%</font>. Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) <font color=\"red\">-48%</font>. La-Z-Boy (NYSE:<a href='https://seekingalpha.com/symbol/LZB' title='La-Z-Boy Incorporated'>LZB</a>) <font color=\"red\">-12%</font>. Libbey (NYSEMKT:<a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a>) <font color=\"red\">-12%</font>. Lifeway Foods (NASDAQ:<a href='https://seekingalpha.com/symbol/LWAY' title='Lifeway Foods, Inc.'>LWAY</a>) <font color=\"red\">-11%</font>. Amira Nature Foods (NYSE:<a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods Ltd.'>ANFI</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469599\" data-linked=\"Tesla and Workhorse Group in consumer gainers; Amira Nature Foods and La-Z-Boy among losers\" data-tweet=\"$WKHS $TSLA $HOME - Tesla and Workhorse Group in consumer gainers; Amira Nature Foods and La-Z-Boy among losers https://seekingalpha.com/news/3469599-tesla-and-workhorse-group-in-consumer-gainers-amira-nature-foods-and-la-z-boy-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469599-tesla-and-workhorse-group-in-consumer-gainers-amira-nature-foods-and-la-z-boy-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469595\" data-ts=\"1559835655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCEL\" target=\"_blank\">FCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469595-fuelcell-slammed-after-hiring-restructuring-firm-dismissing-ceo-bottone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FuelCell slammed after hiring restructuring firm, dismissing CEO Bottone</a></h4><ul><li>FuelCell Energy (<a href='https://seekingalpha.com/symbol/FCEL' title='FuelCell Energy, Inc.'>FCEL</a> <font color='red'>-33.3%</font>) sinks to multi-year lows on disclosing it <a href=\"https://www.sec.gov/Archives/edgar/data/886128/000114420419029911/tv523177_8k.htm\" target=\"_blank\">terminated</a> President and CEO Arthur Bottone after more than eight years at the helm and that it hired Huron Consulting Services to <a href=\"https://www.sec.gov/Archives/edgar/data/886128/000114420419029819/tv523132_8k.htm\" target=\"_blank\">assist restructuring</a> and contingency planning initiatives.</li><li>Oppenheimer's Colin Rusch <a href=\"https://thefly.com/thestreet/realmoney/index.php/FCELid2918702/FCEL-Oppenheimer-downgrades-FuelCell-to-Perform-on-restructuring-CEO-exit\" target=\"_blank\">downgrades</a> shares to Market Perform from Outperform with no price target, saying with FCEL entering into a full restructuring via Huron Consulting and the CEO terminated, the company's strategy for moving forward \"has become increasingly more difficult to predict.\"</li><li>Rush says he had anticipated FCEL would restructure its debt but it is now unclear how the company will move forward both from a capital structure and management perspective.</li><li>Cowen analyst Jeffrey Osborne <a href=\"https://thefly.com/thestreet/realmoney/index.php/FCELid2918671/FCEL-FuelCell-downgraded-to-Market-Perform-from-Outperform-at-Cowen\" target=\"_blank\">also cuts FCEL to Market Perform</a> and lowers his price target to $1 from $2.75 following the hiring of a restructuring firm and dismissal of the CEO.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469595\" data-linked=\"FuelCell slammed after hiring restructuring firm, dismissing CEO Bottone\" data-tweet=\"$FCEL - FuelCell slammed after hiring restructuring firm, dismissing CEO Bottone https://seekingalpha.com/news/3469595-fuelcell-slammed-after-hiring-restructuring-firm-dismissing-ceo-bottone?source=tweet\" data-url=\"https://seekingalpha.com/news/3469595-fuelcell-slammed-after-hiring-restructuring-firm-dismissing-ceo-bottone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469590\" data-ts=\"1559835242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDTX\" target=\"_blank\">CDTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469590-cidara-up-18-ahead-of-rezafungin-data-presentations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cidara up 18% ahead of rezafungin data presentations</a></h4><ul><li>Thinly traded nano cap Cidara Therapeutics (<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics, Inc.'>CDTX</a> <font color=\"green\">+18.1%</font>) is up on more than a 5x surge in volume. Yesterday, it <a href=\"https://seekingalpha.com/pr/17535002-cidara-therapeutics-present-new-data-rezafungin-cloudbreak-antiviral-candidate-influenza-asm\" target=\"_blank\">announced </a>that four abstracts will be presented at ASM Microbe later this month on antifungal rezafungin (three abstracts) and influenza antiviral CB-012.</li><li>Rezafungin is currently being evaluated in a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03667690?term=cidara&amp;rank=4\" target=\"_blank\">ReSTORE</a>, in patients with Candida bloodstream infections and/or invasive Candida infections. A Phase 2 study, <a href=\"https://seekingalpha.com/news/3395075-cidara-30-percent-premarket-mid-stage-rezafungin-data\" target=\"_blank\">STRIVE</a>, was successful.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469590\" data-linked=\"Cidara up 18% ahead of rezafungin data presentations\" data-tweet=\"$CDTX - Cidara up 18% ahead of rezafungin data presentations https://seekingalpha.com/news/3469590-cidara-up-18-ahead-of-rezafungin-data-presentations?source=tweet\" data-url=\"https://seekingalpha.com/news/3469590-cidara-up-18-ahead-of-rezafungin-data-presentations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469588\" data-ts=\"1559835078\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOS\" target=\"_blank\">KTOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469588-kratosminus-1_2-goldman-hits-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kratos -1.2% as Goldman hits sidelines</a></h4><ul><li>Goldman Sachs downgrades Kratos (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOS' title='Kratos Defense & Security Solutions, Inc.'>KTOS</a>) from Buy to Neutral but raises the price target from $22 to $24, implying a 6% increase.</li><li>Kratos shares are <font color=\"red\">down 1.2%</font> to $22.34.</li><li>KTOS has a Neutral <a href=\"https://seekingalpha.com/symbol/KTOS/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469588\" data-linked=\"Kratos -1.2% as Goldman hits sidelines\" data-tweet=\"$KTOS - Kratos -1.2% as Goldman hits sidelines https://seekingalpha.com/news/3469588-kratosminus-1_2-goldman-hits-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3469588-kratosminus-1_2-goldman-hits-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469586\" data-ts=\"1559834621\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MIK\" target=\"_blank\">MIK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469586-michaels-crumbles-after-weak-profit-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michaels crumbles after weak profit outlook</a></h4><ul> <li>Selling pressure on Michaels (<a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies, Inc.'>MIK</a> <font color='red'>-12.5%</font>) sent shares to an all-time low of $7.78 earlier in the session after the retailer's profit guidance (FY20 $2.29 to $2.41 vs. $2.44 consensus) set off some alarm bells.</li> <li>Heading into the report, the Quant rating was flashing <a href=\"https://seekingalpha.com/symbol/MIK/ratings/quant-ratings\" target=\"_blank\">Bearish</a> while the <a href=\"https://seekingalpha.com/symbol/MIK/ratings/sell-side-ratings\" target=\"_blank\">Sell-side community</a> was in the bear camp.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3469452-michaels-minus-1-percent-comparable-sales-miss\" target=\"_blank\">Michaels -1% after comparable sales miss</a> (June 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469586\" data-linked=\"Michaels crumbles after weak profit outlook\" data-tweet=\"$MIK - Michaels crumbles after weak profit outlook https://seekingalpha.com/news/3469586-michaels-crumbles-after-weak-profit-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3469586-michaels-crumbles-after-weak-profit-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469585\" data-ts=\"1559834480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469585-citrix-upgraded-for-desktop-growth-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citrix upgraded for desktop growth potential</a></h4><ul><li>Deutsche Bank upgrades Citrix Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a>) from Hold to Buy and lifts the price target by $10 to $120.</li><li>The firm cites improving growth in the desktop business with the segment up 13% in Q1 and \"projected to be perhaps 5%-9% going forward.\"</li><li>Deutsche says Citrix is \"languishing\" at the current valuation.</li><li>Citrix shares are <font color=\"green\">up 0.9%</font> to $95.46.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469585\" data-linked=\"Citrix upgraded for desktop growth potential\" data-tweet=\"$CTXS - Citrix upgraded for desktop growth potential https://seekingalpha.com/news/3469585-citrix-upgraded-for-desktop-growth-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3469585-citrix-upgraded-for-desktop-growth-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469584\" data-ts=\"1559834470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLT\" target=\"_blank\">FLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469584-fleetcor-sold-100m-plus-in-phony-carbon-offsets-citron-alleges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FleetCor sold $100M-plus in &#39;phony carbon offsets,&#39; Citron alleges</a></h4><ul><li>FleetCor Technologies (<a href='https://seekingalpha.com/symbol/FLT' title='FleetCor Technologies, Inc.'>FLT</a> <font color='red'>-3.5%</font>) tumbles after Citron Research calls the company \"<a href=\"https://twitter.com/CitronResearch/status/1136642469666250752\" target=\"_blank\">the largest clean energy fraud in U.S. history</a>\" and says it has \"fraudulently sold well over $100M in phony carbon offsets.\"</li><li>In a <a href=\"https://citronresearch.com/wp-content/uploads/2019/06/Citron-Exposes-one-of-the-Largest-Clean-Energy-Frauds-in-US-History.pdf\" target=\"_blank\">new report</a>, Citron says FLT's Clean Advantage program \"is an outright 'green fraud' that has brought FleetCor to their Philidor moment and should lead to the immediate resignation of CEO Ronald Clarke.\"</li><li>\"In layman's terms, FleetCor has sold enough phony carbon offsets to land their board of directors in jail for the rest of their lives,\" Citron says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469584\" data-linked=\"FleetCor sold $100M-plus in &#39;phony carbon offsets,&#39; Citron alleges\" data-tweet=\"$FLT - FleetCor sold $100M-plus in &#39;phony carbon offsets,&#39; Citron alleges https://seekingalpha.com/news/3469584-fleetcor-sold-100m-plus-in-phony-carbon-offsets-citron-alleges?source=tweet\" data-url=\"https://seekingalpha.com/news/3469584-fleetcor-sold-100m-plus-in-phony-carbon-offsets-citron-alleges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469583\" data-ts=\"1559834261\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNP\" target=\"_blank\">TNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469583-tsakos-energy-navigationplus-4-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tsakos Energy Navigation +4% after earnings topper</a></h4><ul> <li>Tsakos Energy Navigation (<a href='https://seekingalpha.com/symbol/TNP' title='Tsakos Energy Navigation Limited'>TNP</a> <font color='green'>+3.7%</font>) tracks higher after topping estimates on both lines of its <a href=\"https://seekingalpha.com/pr/17536770-ten-ltd-reports-increased-profits-first-quarter-2019\" target=\"_blank\">Q1</a> report off improved market rate conditions.</li> <li>The company's fleet averaged $21,054 per day in time charter equivalent earnings, an 18.5% increase from last year's level. During the quarter, 73% of the fleet was employed on secured revenue contracts.</li> <li>EBITDA arrived up 53% Y/Y at $64.1M.</li> <li>Shares of TNP are at a two-week high following the earnings release.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469494-tsakos-energy-eps-beats-0_09-beats-revenue\" target=\"_blank\">Tsakos Energy EPS beats by $0.09, beats on revenue</a> (June 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469583\" data-linked=\"Tsakos Energy Navigation +4% after earnings topper\" data-tweet=\"$TNP - Tsakos Energy Navigation +4% after earnings topper https://seekingalpha.com/news/3469583-tsakos-energy-navigationplus-4-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3469583-tsakos-energy-navigationplus-4-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469579\" data-ts=\"1559833371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469579-contravir-pharmaceuticals-leads-healthcare-gainers-rewalk-robotics-and-bellicum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir Pharmaceuticals leads healthcare gainers; ReWalk Robotics and Bellicum Pharmaceuticals among losers</a></h4><ul><li><b>Gainers: </b>ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"green\">+124%</font>. La Jolla Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Company'>LJPC</a>) <font color=\"green\">+39%</font>. Cidara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics, Inc.'>CDTX</a>) <font color=\"green\">+22%</font>. Dynatronics (NASDAQ:<a href='https://seekingalpha.com/symbol/DYNT' title='Dynatronics Corporation'>DYNT</a>) <font color=\"green\">+19%</font>. Cesca Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/KOOL' title='Cesca Therapeutics Inc.'>KOOL</a>) <font color=\"green\">+14%</font>.</li><li><b>Losers: </b>Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"red\">-46%</font>. Benitec Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec Biopharma Limited'>BNTC</a>) <font color=\"red\">-23%</font>. ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"red\">-20%</font>. Xeris Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XERS' title='Xeris Pharmaceuticals, Inc.'>XERS</a>) <font color=\"red\">-20%</font>. Bellicum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/BLCM' title='Bellicum Pharmaceuticals, Inc.'>BLCM</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469579\" data-linked=\"ContraVir Pharmaceuticals leads healthcare gainers; ReWalk Robotics and Bellicum Pharmaceuticals among losers\" data-tweet=\"$HEPA $LJPC $CDTX - ContraVir Pharmaceuticals leads healthcare gainers; ReWalk Robotics and Bellicum Pharmaceuticals among losers https://seekingalpha.com/news/3469579-contravir-pharmaceuticals-leads-healthcare-gainers-rewalk-robotics-and-bellicum?source=tweet\" data-url=\"https://seekingalpha.com/news/3469579-contravir-pharmaceuticals-leads-healthcare-gainers-rewalk-robotics-and-bellicum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469575\" data-ts=\"1559833074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REVG\" target=\"_blank\">REVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469575-rev-group-down-5-post-q2-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REV Group down 5% post Q2 earnings miss</a></h4><ul><li>REV Group (<a href='https://seekingalpha.com/symbol/REVG' title='REV Group, Inc.'>REVG</a> <font color=\"red\">-5%</font>) reported Q2 sales of $615M (+1% Y/Y), driven by continued sales growth in both the Commercial and Recreation segments.</li><li>Segment sales: Fire &amp; Emergency $247.1M (-1.9% Y/Y); Commercial $170M (+7.6% Y/Y); and Recreation $199.7M (+0.45% Y/Y).</li><li>Q2 Gross margin <font color=\"red\">declined by 20 bps</font> to 11.8%; and operating margin<font color=\"red\"> declined by 8 bps</font> to 2.6%.</li><li>Q2 Adj. EBITDA increased by 6.2% Y/Y to $36.1M; and margin<font color=\"green\"> improved by 30 bps</font> to 5.9%.</li><li>Net cash used in operating activities YTD was $39.2M, compared to $43.8M a year ago.</li><li>Total Backlog was at $1.4B (+9.5% Y/Y), as of April 30, 2019.</li><li>During the quarter company repurchased 495,475 for a total cost of $5.3M at an average price per share of $10.77.</li><li><strong>FY19 Outlook:</strong> Revenue $2.4B to $2.6B; Net income $31M to $51M; Adj. net income $66M to $84M; adj. EBITDA $150M to $170M; net cash provided by operating activities of $110M to $130M; and Capex $25M to $30M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469347-rev-group-declares-0_05-dividend\" target=\"_blank\">REV Group declares $0.05 dividend</a> (June 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469345-rev-group-eps-misses-0_01-misses-revenue\" target=\"_blank\">REV Group EPS misses by $0.01, misses on revenue</a> (June 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469575\" data-linked=\"REV Group down 5% post Q2 earnings miss\" data-tweet=\"$REVG - REV Group down 5% post Q2 earnings miss https://seekingalpha.com/news/3469575-rev-group-down-5-post-q2-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3469575-rev-group-down-5-post-q2-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469574\" data-ts=\"1559832994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469574-intelsat-offering-additional-300m-in-debt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat offering additional $300M in debt</a></h4><ul>   <li>Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color=\"green\">+1.9%</font>) says its subsidiary Intelsat Jackson Holdings will <a href=\"https://seekingalpha.com/pr/17536514-intelsat-announces-proposed-offering-300-million-intelsat-jackson-9_750-percent-senior-notes\" target=\"_blank\">offer $300M in 9.75% senior notes</a> due 2025.</li>    <li>Those are additional notes to be part of an existing series of the same notes.</li>    <li>Intelsat Jackson's direct and indirect parent companies are guaranteeing the notes.</li>    <li>Net proceeds will go to general purposes which could include capex, strategic transactions and repaying debt.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469574\" data-linked=\"Intelsat offering additional $300M in debt\" data-tweet=\"$I - Intelsat offering additional $300M in debt https://seekingalpha.com/news/3469574-intelsat-offering-additional-300m-in-debt?source=tweet\" data-url=\"https://seekingalpha.com/news/3469574-intelsat-offering-additional-300m-in-debt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469561\" data-ts=\"1559831501\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469561-insys-triggers-second-volatility-halt-up-45\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insys triggers second volatility halt, up 45%</a></h4><ul><li>Beaten down opioid maker INSYS Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='INSYS Therapeutics, Inc.'>INSY</a> <font color=\"green\">+45%</font>) is up on a 4x surge in volume. The significant spike triggered two volatility halts this morning. Shares peaked at $1.81 (<font color=\"green\">+110%</font>) before retracing.</li><li>No particular news accounts for the action. Shares have been under a heavy cloud related to the potential charges it faces to settle a myriad of opioid-related lawsuits. A bankruptcy filing is still very much on the table.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469561\" data-linked=\"Insys triggers second volatility halt, up 45%\" data-tweet=\"$INSY $INSYQ - Insys triggers second volatility halt, up 45% https://seekingalpha.com/news/3469561-insys-triggers-second-volatility-halt-up-45?source=tweet\" data-url=\"https://seekingalpha.com/news/3469561-insys-triggers-second-volatility-halt-up-45\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469564\" data-ts=\"1559831500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGIH\" target=\"_blank\">LGIH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469564-lgi-homesplus-4-on-strong-may-home-closings-number\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LGI Homes +4% on strong May home closings number</a></h4><ul><li>LGI Homes (NASDAQ:<a href='https://seekingalpha.com/symbol/LGIH' title='LGI Homes, Inc.'>LGIH</a>) <font color=\"green\">jumps 4.0%</font> after reporting<a href=\"https://seekingalpha.com/pr/17536204-lgi-homes-inc-reports-may-2019-home-closings\" target=\"_blank\"> 681 homes closed</a> in May, up 19% Y/Y.</li><li>The May figure also rose from the <a href=\"https://seekingalpha.com/news/3458894-lgi-homes-april-home-closings-1_0-percent-y-y\" target=\"_blank\">612 closings in April</a>.</li><li>Ends first five months of 2019 with 2,521 homes closed, up 4.1% from 2,422 home closings in the same period a year ago.</li><li>94 active selling communities at the end of May 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469564\" data-linked=\"LGI Homes +4% on strong May home closings number\" data-tweet=\"$LGIH - LGI Homes +4% on strong May home closings number https://seekingalpha.com/news/3469564-lgi-homesplus-4-on-strong-may-home-closings-number?source=tweet\" data-url=\"https://seekingalpha.com/news/3469564-lgi-homesplus-4-on-strong-may-home-closings-number\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469562\" data-ts=\"1559831412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469562-natural-gas-inventory-build-tops-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory build tops estimates</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory</a>: <strong>+119 Bcf</strong> vs. +111 Bcf consensus, +114 Bcf last week.</li><li>Futures <font color=\"green\">+0.29%</font> to $2.385.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3469562\" data-linked=\"Natural gas inventory build tops estimates\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory build tops estimates https://seekingalpha.com/news/3469562-natural-gas-inventory-build-tops-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3469562-natural-gas-inventory-build-tops-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469556\" data-ts=\"1559830612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469556-insys-81-jump-triggers-volatility-halt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insys 81% jump triggers volatility halt</a></h4><ul>   <li>Insys Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/INSY' title='INSYS Therapeutics, Inc.'>INSY</a>) has been halted for volatility after an <font color=\"green\">81% jump</font>.</li>    <li>The stock had declined postmarket last night (before turning up on a few small trades) in the aftermath of a <a href=\"https://seekingalpha.com/news/3469403-insys-settles-opioid-charges-225m-guilty-pleas\" target=\"_blank\">government settlement</a> resolving civil and criminal investigations into opioid marketing, with a $225M fine.</li>    <li>In addition, two board members said <a href=\"https://seekingalpha.com/filing/4522678\" target=\"_blank\">they would resign</a> along with the settlement: Chairman Steven Meyer and director Pierre Lapalme.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469556\" data-linked=\"Insys 81% jump triggers volatility halt\" data-tweet=\"$INSY $INSYQ - Insys 81% jump triggers volatility halt https://seekingalpha.com/news/3469556-insys-81-jump-triggers-volatility-halt?source=tweet\" data-url=\"https://seekingalpha.com/news/3469556-insys-81-jump-triggers-volatility-halt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469555\" data-ts=\"1559830461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOV\" target=\"_blank\">HOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469555-hovnanianminus-2_2-q2-bottom-line-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hovnanian -2.2% as Q2 bottom line disappoints</a></h4><ul><li>Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">slumps 2.2%</font> after<a href=\"https://seekingalpha.com/pr/17536998-hovnanian-enterprises-reports-fiscal-2019-second-quarter-results\" target=\"_blank\"> fiscal Q2 loss per share </a>of $2.56 came in worse than the $1.77 per share loss expected.</li><li>Compares with a loss of $1.65 per share in the year-ago quarter.</li><li>Total revenue for the quarter ended April 30, 2019 of $440.7M fell from $502.5M in the year-ago quarter and compares with the average analyst estimate of $441.0M.</li><li>Q2 consolidated deliveries of 1,085 homes fell 11% Y/Y.</li><li>And contract cancellation rate increased in the quarter to 19% from 17% in the year-ago quarter.</li><li>Q2 number of consolidated contracts rose 10% to 1,546 homes from 1,404 a year ago. During May 2019, the number of consolidated contracts increased 20% to 536 homes.</li><li>Homebuilding gross margin, after cost of sales interest expense and land charges, was 13.3% vs. 13.8% a year ago.</li><li><strong>Year outlook:</strong> Sees H2 outperforming H1, resulting in profit for the full year, when excluding land-related charges, gains or losses on extinguishment of debt, and other non-recurring items.</li><li><a href=\"http://www.khov.com/investor-relations/hovinvestors\" target=\"_blank\">Conference call</a> at 11:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469520-hovnanian-eps-misses-0_79-revenue-line\" target=\"_blank\">Hovnanian EPS misses by $0.79,  revenue in-line</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469555\" data-linked=\"Hovnanian -2.2% as Q2 bottom line disappoints\" data-tweet=\"$HOV - Hovnanian -2.2% as Q2 bottom line disappoints https://seekingalpha.com/news/3469555-hovnanianminus-2_2-q2-bottom-line-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3469555-hovnanianminus-2_2-q2-bottom-line-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469554\" data-ts=\"1559830391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DATA\" target=\"_blank\">DATA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469554-tableau-domo-drop-on-looker-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tableau, Domo drop on Looker acquisition</a></h4><ul><li>Tableau Software (NYSE:<a href='https://seekingalpha.com/symbol/DATA' title='Tableau Software, Inc.'>DATA</a>) <font color=\"red\">drops 3.5%</font> and Domo (NASDAQ:<a href='https://seekingalpha.com/symbol/DOMO' title='Domo, Inc.'>DOMO</a>) <font color=\"red\">falls 1.7%</font> after Google <a href=\"https://seekingalpha.com/news/3469541-google-pays-2_6b-looker\" target=\"_blank\">acquires </a>competitor Looker for $2.6B to add to Google Cloud.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469554\" data-linked=\"Tableau, Domo drop on Looker acquisition\" data-tweet=\"$DATA $DOMO - Tableau, Domo drop on Looker acquisition https://seekingalpha.com/news/3469554-tableau-domo-drop-on-looker-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3469554-tableau-domo-drop-on-looker-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469553\" data-ts=\"1559830193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUB\" target=\"_blank\">CUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469553-cubic-awarded-contracts-worth-150m-to-deliver-training-support-and-equipment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cubic awarded contracts worth ~$150M to deliver training support and equipment</a></h4><ul><li>Cubic\u2019s (<a href='https://seekingalpha.com/symbol/CUB' title='Cubic Corporation'>CUB</a> <font color=\"red\">-0.4%</font>) Cubic Global Defense business division <a href=\"https://seekingalpha.com/pr/17536452-cubic-awarded-contracts-deliver-training-support-equipment-indo-pacific-region-customer\" target=\"_blank\">awarded</a> several contracts totaling ~$150M from various customers in the Indo-Pacific region.</li><li>The contracts will provide Air Combat Maneuvering Instrumentation, training support for Combat Training Centers and deliver upgrades and maintenance services for the region's live fire ranges.</li><li>The total value of the awarded contracts includes options to extend as well as support for future overseas exercises and additional services where needed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469553\" data-linked=\"Cubic awarded contracts worth ~$150M to deliver training support and equipment\" data-tweet=\"$CUB - Cubic awarded contracts worth ~$150M to deliver training support and equipment https://seekingalpha.com/news/3469553-cubic-awarded-contracts-worth-150m-to-deliver-training-support-and-equipment?source=tweet\" data-url=\"https://seekingalpha.com/news/3469553-cubic-awarded-contracts-worth-150m-to-deliver-training-support-and-equipment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469545\" data-ts=\"1559829925\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MIND\" target=\"_blank\">MIND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469545-mitcham-industriesminus-2_7-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitcham Industries -2.7% post Q1 results</a></h4><ul><li>Mitcham Industries (<a href='https://seekingalpha.com/symbol/MIND' title='Mitcham Industries, Inc.'>MIND</a> <font color=\"red\">-2.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17536041-mitcham-industries-reports-fiscal-2020-first-quarter-results\" target=\"_blank\">Q1</a> revenue growth of 29.6% Y/Y to $9.86M, the improvement was driven primarily by further growth within the Marine Technology Products segment.</li><li>Marine technology products segment rose 61% Y/Y to $6M of which; Seamap sales was +147% Y/Y to $4.3M; Klein sales +3% Y/Y to $1.6M and 0.1M of SAP.</li><li>Equipment Leasing segment was flat Y/Y to $3.9M of which; Lease pool equipment sales were $0.42M down 65% Y/Y and other equipment sales were also -26.3% Y/Y to $0.14M.</li><li>Gross margin <font color=\"green\">increased 2,026 bps</font> to 37.4%.</li><li>Adj. EBITDA was $0.06M compared to a loss of ~$1.56M in the same period last year.</li><li>Capital structure remains strong, with no funded debt on our balance sheet and ample liquidity, including cash and equivalents of $8.1M.</li><li>Backlog of firm orders grew to $11M, an increase of approximately 26% Y/Y.</li><li>Additionally, received ~$5.1M in bookings subsequent to April 30, included in this recent activity are orders for our new MA-X sonar technology which was unveiled at the Ocean Business conference in April of this year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469358-mitcham-eps-misses-0_05-misses-revenue\" target=\"_blank\">Mitcham EPS misses by $0.05, misses on revenue</a> (Jun. 05 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3469545\" data-linked=\"Mitcham Industries -2.7% post Q1 results\" data-tweet=\"$MIND - Mitcham Industries -2.7% post Q1 results https://seekingalpha.com/news/3469545-mitcham-industriesminus-2_7-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3469545-mitcham-industriesminus-2_7-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469548\" data-ts=\"1559829805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469548-la-jolla-pharma-up-15-on-positive-ljpcminus-401-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La Jolla Pharma up 15% on positive LJPC-401 data</a></h4><ul><li>La Jolla Pharmaceutical Company (<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Company'>LJPC</a> <font color=\"green\">+14.5%</font>) is up on modest volume in early trade on the heels of <a href=\"https://seekingalpha.com/pr/17536936-la-jolla-pharmaceutical-company-announces-positive-results-pre-specified-interim-analysis\" target=\"_blank\">positive interim dat</a>a from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03395704?term=ljpc-401&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating LJPC-401 (synthetic human hepcidin) in patients with <a href=\"https://ghr.nlm.nih.gov/condition/hereditary-hemochromatosis\" target=\"_blank\">hereditary hemochromatosis</a>, a disorder caused by the excessive absorption of iron from the diet that can lead to tissue and organ damage.</li><li>The primary endpoint is the change in blood iron levels at week 16 as measured by a laboratory test called transferrin saturation &#40;TSAT&#41;.</li><li>Preliminary results on 26 patients who completed the 16-week treatment period (12 - treated, 14 - placebo) showed an average reduction in TSAT of 42% compared to an average reduction of 6% in the control group, a statistically significant separation (p&lt;0.0001).</li><li>There were only three phlebotomy procedures (blood draws) in two treated patients versus 24 in nine patients in the placebo group.</li><li>On the safety front, the most frequent treatment-emergent adverse event was injection site reaction (79%), all mild or moderate.</li><li>Topline results should be available in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469548\" data-linked=\"La Jolla Pharma up 15% on positive LJPC-401 data\" data-tweet=\"$LJPC - La Jolla Pharma up 15% on positive LJPC-401 data https://seekingalpha.com/news/3469548-la-jolla-pharma-up-15-on-positive-ljpcminus-401-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3469548-la-jolla-pharma-up-15-on-positive-ljpcminus-401-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469546\" data-ts=\"1559829623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVE\" target=\"_blank\">SAVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469546-goldman-sachs-sees-bouncy-ride-for-spirit-airlines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs sees bouncy ride for Spirit Airlines</a></h4><ul> <li>Goldman Sachs drops Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a> <font color=\"red\">-0.9%</font>) to a Neutral rating from Buy on <a href=\"https://www.cnbc.com/2019/06/06/goldman-sachs-upgrades-united-airlines-to-buy-sees-stock-climbing-32percent.html\" target=\"_blank\">concerns</a> that the company will not see the expected bounce from several initiatives.</li> <li>\"We are now less confident that these initiatives will ramp up enough in the back half of 2019 to offset the materially tougher comparables SAVE faces given the slower-than-expected start,\" warns the firm.</li> <li>The seatbelt light is on for investors as GS expects choppy trading ahead on Spirit.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3469546\" data-linked=\"Goldman Sachs sees bouncy ride for Spirit Airlines\" data-tweet=\"$SAVE - Goldman Sachs sees bouncy ride for Spirit Airlines https://seekingalpha.com/news/3469546-goldman-sachs-sees-bouncy-ride-for-spirit-airlines?source=tweet\" data-url=\"https://seekingalpha.com/news/3469546-goldman-sachs-sees-bouncy-ride-for-spirit-airlines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469539\" data-ts=\"1559828511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EROS\" target=\"_blank\">EROS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469539-erosminus-31_5-care-slashes-credit-ratings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eros -31.5% as Care slashes credit ratings</a></h4><ul>   <li>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) has <font color=\"red\">slid 31.5%</font> out of the open at NYSE following a 10-notch cut to the credit rating of unit Eros International Media at Care Ratings.</li>    <li>The agency lowered the Eros subsidiary's long-term bank facilities rating to D from BBB- alongside delays in debt servicing, noting that a slowdown in collection from debtors leads to cash flow issues.</li>    <li>It also cut long-term cash credit bank facilities to D from BBB-, and cut short-term bank facilities to D from A3.</li>    <li><a href=\"https://seekingalpha.com/pr/17537004-eros-international-plc-issues-statement-announces-fiscal-year-end-2019-earnings-date\" target=\"_blank\">In response</a>, Eros says \"Eros International PLC and all of its subsidiaries have met and continue to meet all debt service commitments. The company retains the full faith and confidence of our lenders.\"</li>    <li>The company adds that it will release fiscal year-end 2019 results on July 15 at 8:30 a.m. ET.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469539\" data-linked=\"Eros -31.5% as Care slashes credit ratings\" data-tweet=\"$EROS - Eros -31.5% as Care slashes credit ratings https://seekingalpha.com/news/3469539-erosminus-31_5-care-slashes-credit-ratings?source=tweet\" data-url=\"https://seekingalpha.com/news/3469539-erosminus-31_5-care-slashes-credit-ratings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469536\" data-ts=\"1559828262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469536-baml-warns-on-denim-risk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BAML warns on denim risk</a></h4><ul> <li>Bank of America Merrill Lynch weighs in on the negative side on newly-trading Kontoor Brands (<a href='https://seekingalpha.com/symbol/KTB' title='Kontoor Brands, Inc.'>KTB</a> <font color='red'>-3.4%</font>).</li> <li>\"We expect multiple contraction as growth misses plan due to a tough retail environment and underinvestment in the Lee and Wrangler brands,\" warns the firm as it initiates at Underperform.</li> <li>BAML applies a discounted 2020 EV/EBITDA multiple of 6X to Kontoor to derive a price objective of $24. \"We think a discount is warranted given our outlook for below peer growth and because we think the company is over-earning in the near-term,\" writes analyst Heather Balsky.</li> <li>Shares of Levi Strauss (<a href='https://seekingalpha.com/symbol/LEVI' title='Levi Strauss & Co.'>LEVI</a>) are also on watch, with BAML's comments on denim tariff risk potentially creating a ripple.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3469536\" data-linked=\"BAML warns on denim risk\" data-tweet=\"$KTB $LEVI - BAML warns on denim risk https://seekingalpha.com/news/3469536-baml-warns-on-denim-risk?source=tweet\" data-url=\"https://seekingalpha.com/news/3469536-baml-warns-on-denim-risk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469531\" data-ts=\"1559828233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXGT\" target=\"_blank\">AXGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469531-axovant-up-8-premarket-on-parkinsons-gene-therapy-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axovant up 8% premarket on Parkinson&#39;s gene therapy data</a></h4><ul><li>Thinly traded micro cap Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) is up <font color=\"green\">8%</font> premarket on modestly higher volume in reaction to encouraging <a href=\"https://seekingalpha.com/pr/17536547-axovant-announces-6-month-follow-data-first-cohort-sunrise-pd-phase-2-trial-axo-lenti-pd\" target=\"_blank\">six-month follow-up data</a> from the first dose cohort in a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03720418?term=sunrise-pd&amp;rank=1\" target=\"_blank\">SUNRISE-PD</a>, evaluating gene therapy AXO-Lenti-PD in Parkinson's disease &#40;PD&#41; patients.</li><li>At month 6, patients experienced an average improvement of 29% from baseline in a PD symptom scale called UPDRS III. The average equivalent daily dose of levodopa, the most widely used medicine to treat PD, decreased 21% from baseline while the ability to perform daily functional activities improved by an average of 18% (Rush Dyskinesia Rating Scale). ON time without dyskinesia improved 2.7 hours from baseline.</li><li>On the safety front, AXO-Lenti-PD was generally well-tolerated with no serious treatment-emergent adverse events reported.</li><li>Initial three-month data on the first patient in the second cohort should be available in Q4.</li><li>Data from the first child with a rare inherited lysosomal storage disorder called <a href=\"https://ghr.nlm.nih.gov/condition/gm1-gangliosidosis\" target=\"_blank\">GM1 gangliosidosis</a> dosed with gene therapy AXO-AAV-GM2 should be available in H2.</li><li>On another note, the company has terminated its license and collaboration agreement with Benitec Biopharma Ltd. (<a href='https://seekingalpha.com/symbol/BNTC' title='Benitec Biopharma Limited'>BNTC</a> <font color=\"red\">-8.9%</font>) in its entirety (<a href=\"https://seekingalpha.com/pr/17536713-update-oculopharyngeal-muscular-dystrophy-program\" target=\"_blank\">effective September 3</a>), including gene therapy candidate AXO-AAV-OPMD, in preclinical development for oculopharyngeal muscular dystrophy.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469531\" data-linked=\"Axovant up 8% premarket on Parkinson&#39;s gene therapy data\" data-tweet=\"$AXGT $BNTC - Axovant up 8% premarket on Parkinson&#39;s gene therapy data https://seekingalpha.com/news/3469531-axovant-up-8-premarket-on-parkinsons-gene-therapy-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3469531-axovant-up-8-premarket-on-parkinsons-gene-therapy-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469529\" data-ts=\"1559827546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVGW\" target=\"_blank\">CVGW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469529-calavo-rides-strong-avocado-demand-to-record-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calavo rides strong avocado demand to record quarter</a></h4><ul> <li>Calavo Growers (NASDAQ:<a href='https://seekingalpha.com/symbol/CVGW' title='Calavo Growers, Inc.'>CVGW</a>) is tracking higher after posting a 16% jump in net income in <a href=\"https://seekingalpha.com/pr/17536867-calavo-growers-inc-announces-record-fiscal-2019-second-quarter-results\" target=\"_blank\">Q2</a> off a 8.3% gain in revenue.</li> <li>\"Avocado unit volume and gross profit increased significantly year over year\u2014indicative of consumer demand that continues to track strongly,\" notes CEO Lee Cole.</li> <li>\"With our breadth and depth of sourcing, sales and production capabilities, coupled with our financial resources and human capital, we are well positioned to capitalize on industry expansion that shows no signs of abating,\" he adds.</li> <li>Calavo expects a gross profit increase of ~50% for the full year in the fresh segment. Tariffs were given scant attention in Calavo's release.</li> <li>Calavo is <font color=\"green\">up 2.02%</font> premarket to extend on this year's +25% rally.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469518-calavo-growers-eps-beats-0_15-beats-revenue\" target=\"_blank\">Calavo Growers EPS beats by $0.15, beats on revenue</a> (June 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469529\" data-linked=\"Calavo rides strong avocado demand to record quarter\" data-tweet=\"$CVGW - Calavo rides strong avocado demand to record quarter https://seekingalpha.com/news/3469529-calavo-rides-strong-avocado-demand-to-record-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3469529-calavo-rides-strong-avocado-demand-to-record-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469516\" data-ts=\"1559826839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469516-home-cldr-and-mik-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HOME, CLDR and MIK among premarket losers</a></h4><ul><li>Motif Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/MTFB' title='Motif Bio plc'>MTFB</a>) <font color=\"red\">-48%</font> on <a href=\"https://seekingalpha.com/news/3469433-motif-bio-quite-iclaprim-nda-shares-35-percent-premarket\" target=\"_blank\">announcing</a> path forward for Iclaprim.</li><li>At Home Group (NYSE:<a href='https://seekingalpha.com/symbol/HOME' title='At Home Group Inc.'>HOME</a>) <font color=\"red\">-37%</font> on <a href=\"https://seekingalpha.com/news/3469436-home-group-eps-misses-0_01-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) <font color=\"red\">-37%</font> on <a href=\"https://seekingalpha.com/news/3469352-cloudera-eps-beats-0_10-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Kirkland's (NASDAQ:<a href='https://seekingalpha.com/symbol/KIRK' title='Kirkland&#39;s, Inc.'>KIRK</a>) <font color=\"red\">-28%</font> on <a href=\"https://seekingalpha.com/news/3469435-kirklands-eps-misses-0_13-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>MICT (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">-26%</font> after tender offer <a href=\"https://seekingalpha.com/news/3469490-mict-plunges-tender-offer-terminated\" target=\"_blank\">terminated</a>.</li><li>Eros International (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) <font color=\"red\">-25%</font>.</li><li>The Michaels Companies (NASDAQ:<a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies, Inc.'>MIK</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3469442-michaels-companies-eps-line-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>ADMA Biologics (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMA' title='ADMA Biologics, Inc.'>ADMA</a>) <font color=\"red\">-10%</font>.</li><li>GTx (NASDAQ:<a href='https://seekingalpha.com/symbol/GTXI' title='GTx, Inc.'>GTXI</a>) <font color=\"red\">-10%</font>.</li><li>ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a>) <font color=\"red\">-10%</font>.</li><li>DelMar Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/DMPI' title='DelMar Pharmaceuticals, Inc.'>DMPI</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469516\" data-linked=\"HOME, CLDR and MIK among premarket losers\" data-tweet=\"$MTFB $HOME $CLDR - HOME, CLDR and MIK among premarket losers https://seekingalpha.com/news/3469516-home-cldr-and-mik-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469516-home-cldr-and-mik-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469515\" data-ts=\"1559826697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469515-cien-ctrv-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CIEN, CTRV among premarket gainers</a></h4><ul><li>ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) <font color=\"green\">+123%</font> on encouraging CRV431 <a href=\"https://seekingalpha.com/news/3469504-contravir-139-percent-premarket-encouraging-crv431-data\" target=\"_blank\">data</a>.</li><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) <font color=\"green\">+26%</font> on <a href=\"https://seekingalpha.com/news/3469342-stitch-fix-eps-beats-0_10-beats-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Ciena (NYSE:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) <font color=\"green\">+19%</font> on <a href=\"https://seekingalpha.com/news/3469443-ciena-eps-beats-0_07-beats-revenue\" target=\"_blank\">Q2 results</a>.</li><li>vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics Inc.'>VTVT</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/pr/17536565-vtv-therapeutics-announces-positive-topline-results-part-1-phase-2-simplici-t1-trial-patients\" target=\"_blank\">topline results</a> from part 1 of the phase 2 simplici-T1 trial in patients with type 1 diabetes.</li><li>Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3469496-health-insurance-innovations-acquires-direct-consumer-platform-shares-6-percent\" target=\"_blank\">acquiring</a> direct-to-consumer platform.</li><li>Cidara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CDTX' title='Cidara Therapeutics, Inc.'>CDTX</a>) <font color=\"green\">+10%</font>.</li><li>InflaRx N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/IFRX' title='InflaRx N.V.'>IFRX</a>) <font color=\"green\">+8%</font>.</li><li>Axovant Gene Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/AXGT' title='Axovant Gene Therapies Ltd.'>AXGT</a>) <font color=\"green\">+6%</font> on six-month <a href=\"https://seekingalpha.com/pr/17536547-axovant-announces-6-month-follow-data-first-cohort-sunrise-pd-phase-2-trial-axo-lenti-pd\" target=\"_blank\">follow-up data</a> from the first cohort of SUNRISE-PD Phase 2 trial of AXO-Lenti-PD for the treatment of Parkinson\u2019s disease</li><li>Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469515\" data-linked=\"CIEN, CTRV among premarket gainers\" data-tweet=\"$HEPA $SFIX $CIEN - CIEN, CTRV among premarket gainers https://seekingalpha.com/news/3469515-cien-ctrv-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3469515-cien-ctrv-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469514\" data-ts=\"1559826436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DERM\" target=\"_blank\">DERM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469514-mizuho-likes-dermira-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho likes Dermira, shares up 3% premarket</a></h4><ul><li>Mizuho has upgraded Dermira (NASDAQ:<a href='https://seekingalpha.com/symbol/DERM' title='Dermira, Inc.'>DERM</a>) to Buy with a $14 (56% upside) price target. Shares are up <font color=\"green\">3%</font> premarket, albeit on only 100 shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469514\" data-linked=\"Mizuho likes Dermira, shares up 3% premarket\" data-tweet=\"$DERM - Mizuho likes Dermira, shares up 3% premarket https://seekingalpha.com/news/3469514-mizuho-likes-dermira-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3469514-mizuho-likes-dermira-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469511\" data-ts=\"1559826159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469511-jaguar-health-down-11-in-1-70-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar Health down 11% in 1:70 reverse split</a></h4><ul> <li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <a href=\"https://seekingalpha.com/pr/17536701-jaguar-health-inc-announces-1minus-70-reverse-stock-split\" target=\"_blank\">announces</a> that its 1:70 reverse stock split of common shares will be effective on June 7.</li><li>Post-split trading will commence on June 7.</li><li>Shares are down <font color=\"red\">11%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469511\" data-linked=\"Jaguar Health down 11% in 1:70 reverse split\" data-tweet=\"$JAGX - Jaguar Health down 11% in 1:70 reverse split https://seekingalpha.com/news/3469511-jaguar-health-down-11-in-1-70-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3469511-jaguar-health-down-11-in-1-70-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469505\" data-ts=\"1559825711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HL\" target=\"_blank\">HL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469505-hecla-mining-to-cut-spending-for-nevada-operations\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hecla Mining to cut spending for Nevada operations</a></h4><ul><li>Hecla Mining (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a>) <font color=\"green\">+5.5%</font> pre-market after announcing plans to significantly <a href=\"https://seekingalpha.com/pr/17536348-hecla-reduces-spending-nevada-operations\" target=\"_blank\">reduce planned development spending</a> on its Nevada mining operations following the heavy investment made during Q1 and Q2.</li><li>HL says the       Nevada operations have generated less cash flow than expected, so       it will curtail most development and lay off 25% of the Nevada workforce with the       goal of the operation generating positive cash flow in H2.</li><li>HL plans to cut 2019 capital spending by $12M, exploration expenses by $9M and G&amp;A and other costs by $4M, for a total $25M planned reduction in spending.</li><li>HL now forecasts 2019 Nevada production of 60K oz. of gold at an all-in sustaining       cost after by-product credits of $1,700/oz.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469505\" data-linked=\"Hecla Mining to cut spending for Nevada operations\" data-tweet=\"$HL - Hecla Mining to cut spending for Nevada operations https://seekingalpha.com/news/3469505-hecla-mining-to-cut-spending-for-nevada-operations?source=tweet\" data-url=\"https://seekingalpha.com/news/3469505-hecla-mining-to-cut-spending-for-nevada-operations\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469504\" data-ts=\"1559825682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRV\" target=\"_blank\">CTRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469504-contravir-up-139-premarket-on-encouraging-crv431-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir up 139% premarket on encouraging CRV431 data</a></h4><ul><li>Thinly traded nano cap ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) is up <font color=\"green\">139%</font> premarket on increased volume in reaction to <a href=\"https://seekingalpha.com/pr/17536681-contravir-pharmaceuticals-sets-stage-crv431-development-nash-positive-results-second-model\" target=\"_blank\">positive preclinical data</a> on NASH candidate CRV431.</li><li>The company says CRV431, an inhibitor of a family of proteins called <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175980/\" target=\"_blank\">cyclophilins</a>, significantly decreased the extend of scarring in a second animal (mouse) model of liver fibrosis.</li><li>Intercept Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals, Inc.'>ICPT</a>) obeticholic acid was used as a comparator, failing to demonstrate a decrease in fibrosis.</li><li>The study was conducted at the Scripps Research Institute.</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469504\" data-linked=\"ContraVir up 139% premarket on encouraging CRV431 data\" data-tweet=\"$CTRV $ICPT $HEPA - ContraVir up 139% premarket on encouraging CRV431 data https://seekingalpha.com/news/3469504-contravir-up-139-premarket-on-encouraging-crv431-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3469504-contravir-up-139-premarket-on-encouraging-crv431-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469502\" data-ts=\"1559825400\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KIRK\" target=\"_blank\">KIRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469502-kirklandsminus-28-after-earnings-dud\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kirkland&#39;s -28% after earnings dud</a></h4><ul> <li>Kirkland's (NASDAQ:<a href='https://seekingalpha.com/symbol/KIRK' title='Kirkland&#39;s, Inc.'>KIRK</a>) is in freefall after posting a disappointing <a href=\"https://seekingalpha.com/pr/17536404-kirklands-reports-first-quarter-2019-results-updates-2019-earnings-guidance\" target=\"_blank\">FQ1</a> earnings report.</li> <li>Total sales were down 9.1% during the quarter and comparable store sales fell off 10.7%. Store sales were impacted by negative store traffic and a decline in average ticket, which was partially offset by an improvement in conversion.</li> <li>Kirkland's reports a net loss of $8.9M for the quarter vs. -$0.9M a year ago.</li> <li>\"The environment remains challenging, and slower-than-expected sales in the first quarter are evidence that we must continue to fast-track our strategy to improve the business,\" says Kirkland's CEO Woody Woodward.</li> <li>Looking ahead, the retailer expects FY20 EPS of $0.00 to $0.15 vs. $0.15 to $0.30 prior view and $0.18 consensus.</li> <li>Shares of KIRK are <font color=\"red\">down 27.90%</font> premarket to $3.05.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469435-kirklands-eps-misses-0_13-misses-revenue\" target=\"_blank\">Kirkland's EPS misses by $0.13, misses on revenue</a> (June 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469502\" data-linked=\"Kirkland&#39;s -28% after earnings dud\" data-tweet=\"$KIRK - Kirkland&#39;s -28% after earnings dud https://seekingalpha.com/news/3469502-kirklandsminus-28-after-earnings-dud?source=tweet\" data-url=\"https://seekingalpha.com/news/3469502-kirklandsminus-28-after-earnings-dud\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469496\" data-ts=\"1559824465\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469496-health-insurance-innovations-acquires-direct-to-consumer-platform-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Insurance Innovations acquires direct-to-consumer platform; shares up 6%</a></h4><ul><li>Health Insurance Innovations (NASDAQ:<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations, Inc.'>HIIQ</a>) has <a href=\"https://seekingalpha.com/pr/17536689-health-insurance-innovations-inc-announces-transformative-acquisition-material-corporate\" target=\"_blank\">acquired</a> TogetherHealth, a direct-to-consumer platform aimed at the \"over 65\" insurance market.</li><li>Under the terms of the deal, HIIQ paid ~$50M in cash plus 630K shares of Class A common stock. It also included a five-year earnout provision.</li><li>The transaction will add at least $10M to HIIQ's 2019 non-GAAP EBITDA.</li><li><strong>Updated 2019 guidance</strong>: revenues: $450M - 460M from $430M - 440M; non-GAAP EBITDA: $82M - 87M from $72M - 77M; non-GAAP EPS: $3.80 - 4.05 from $3.50 - 3.75.</li><li>The company has established a new $215M credit facility that includes a $150M term loan and a $65M revolver. The term loan will fund the refinancing of $65M of existing debt and the cash portion of the transaction.</li><li>Management will host a conference call this morning at 9:00 am ET to discuss the deal.</li><li>Shares are up <font color=\"green\">6%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469496\" data-linked=\"Health Insurance Innovations acquires direct-to-consumer platform; shares up 6%\" data-tweet=\"$HIIQ - Health Insurance Innovations acquires direct-to-consumer platform; shares up 6% https://seekingalpha.com/news/3469496-health-insurance-innovations-acquires-direct-to-consumer-platform-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3469496-health-insurance-innovations-acquires-direct-to-consumer-platform-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469490\" data-ts=\"1559824157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MICT\" target=\"_blank\">MICT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469490-mict-plunges-after-tender-offer-terminated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MICT plunges after tender offer terminated</a></h4><ul><li>MICT, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/MICT' title='MICT, Inc.'>MICT</a>) <font color=\"red\">tumbles 35.1%</font> premarket after BNN Technology <a href=\"https://seekingalpha.com/pr/17536202-bnn-technology-plc-announces-termination-tender-offer-shares-mict-common-stock\" target=\"_blank\">terminated</a> its previously announced tender offer to purchase up to 1,953,423 shares of MICT common stock at a purchase price of $1.65 per share.</li><li>BNN's obligation to purchase the shares of common stock of MICT pursuant to the tender offer was subject to various terms and conditions, including a condition that neither MICT nor its subsidiaries has proposed the issuance or sale of any additional equity securities.</li><li>On June 4, 2019, howevr, MICT entered into a securities purchase agreement with a group of investors to issue shares of preferred stock and warrants to purchase shares  in a private placement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469490\" data-linked=\"MICT plunges after tender offer terminated\" data-tweet=\"$MICT - MICT plunges after tender offer terminated https://seekingalpha.com/news/3469490-mict-plunges-after-tender-offer-terminated?source=tweet\" data-url=\"https://seekingalpha.com/news/3469490-mict-plunges-after-tender-offer-terminated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469486\" data-ts=\"1559823377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHR\" target=\"_blank\">WHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469486-whirlpool-sells-home-beer-system-innovation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whirlpool sells home beer system innovation</a></h4><ul> <li>Whirlpool (NYSE:<a href='https://seekingalpha.com/symbol/WHR' title='Whirlpool Corporation'>WHR</a>) announces that it finalized the sale of its Vessi Fermentor to 80West Labs for an undisclosed amount.</li><li>The Vessi home beer fermentation system was developed by Whirlpool's WLabs rapid innovation branch.</li>                 <li>Vessi was born out of Whirlpool's internal business concept challenge to employees, called SPARK. The company notes that with several homebrewing enthusiasts on the staff, the idea quickly took off and was developed further at WLabs.</li>  <li>WHR  <font color=\"green\">+1.21%</font> premarket to  $127.11 (<a href=\"https://seekingalpha.com/news/3469469-keybanc-bullish-whirlpool\" target=\"_blank\">KeyBanc upgrade</a>)</li><li>Source: <a href=\"https://seekingalpha.com/pr/17536597-whirlpool-corporation-finalizes-sale-vessi-fermentor-80west-labs\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3469486\" data-linked=\"Whirlpool sells home beer system innovation\" data-tweet=\"$WHR - Whirlpool sells home beer system innovation https://seekingalpha.com/news/3469486-whirlpool-sells-home-beer-system-innovation?source=tweet\" data-url=\"https://seekingalpha.com/news/3469486-whirlpool-sells-home-beer-system-innovation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469484\" data-ts=\"1559822843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIG\" target=\"_blank\">SIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469484-signetplus-2-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signet +2% after earnings topper</a></h4><ul> <li>Signet Jewelers (NYSE:<a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a>) reports comparable sales fell 1.3% in <a href=\"https://seekingalpha.com/pr/17536431-signet-jewelers-reports-first-quarter-fiscal-2020-financial-results\" target=\"_blank\">Q1</a> vs. -0.8% consensus as both the Jared (-2%) and Kay (-1.4%) brands showed drops. Standing out on the positive side, the Piercing Pagoda business generated a 13.5% comp during the quarter. E-commerce sales rose 5.3% in Q1 to account for 10.8% of all sales.</li> <li>GAAP gross margin improved 220 bps to 34.9% of sales due largely to a positive impact from credit outsourcing.</li> <li>Signet generated free cash flow of $80.8M during the quarter amid a significantly lower use of cash for inventory.</li> <li>Looking ahead, Signet guides for FY20 revenue of $6.00B to $6.20B vs. $6.02B consensus and EPS of $2.88 to $3.17 vs. $2.99 consensus. FY20 same-store sales are seen falling in a range of -2.5% to -1.5%.</li> <li>Shares of Signet are <font color=\"green\">up 1.75%</font> premarket to $19.76.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3469438-signet-eps-beats-0_32-beats-revenue\" target=\"_blank\">Signet EPS beats by $0.32, beats on revenue</a> (June 6)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3469484\" data-linked=\"Signet +2% after earnings topper\" data-tweet=\"$SIG - Signet +2% after earnings topper https://seekingalpha.com/news/3469484-signetplus-2-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3469484-signetplus-2-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469483\" data-ts=\"1559822769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKYW\" target=\"_blank\">SKYW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469483-skywest-traffic-rose-8_3-in-may\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SkyWest traffic rose 8.3% in May</a></h4><ul> <li>SkyWest (NASDAQ:<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a>) <a href=\"https://seekingalpha.com/pr/17536692-skywest-inc-reports-may-2019-traffic\" sasource=\"qp_sum_news_2\" target=\"_blank\">reports</a> total block hours rose 8.3% to 124.404K in May.</li><li>Departures increased 8.7% to 72,713.</li><li>Passengers flown expanded 11.7% to 3.846M.</li><li>May load factor improved 10 bps to 83.9%.</li><li>YTD load factor up 30 bps to 80.4%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469483\" data-linked=\"SkyWest traffic rose 8.3% in May\" data-tweet=\"$SKYW - SkyWest traffic rose 8.3% in May https://seekingalpha.com/news/3469483-skywest-traffic-rose-8_3-in-may?source=tweet\" data-url=\"https://seekingalpha.com/news/3469483-skywest-traffic-rose-8_3-in-may\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469481\" data-ts=\"1559822669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLEX\" target=\"_blank\">FLEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469481-flexplus-5-on-goldman-conviction-list-addition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flex +5% on Goldman Conviction List addition</a></h4><ul><li>Goldman Sachs upgrades Flex (NASDAQ:<a href='https://seekingalpha.com/symbol/FLEX' title='Flex Ltd.'>FLEX</a>) from Neutral to Buy and adds the company to its Conviction List.</li><li>The firm cites the recent pullback with shares down 18% from a May peak, which created an \"attractive\" and \"compelling\" valuation.</li><li>Goldman also thinks Flex has the opportunity to expand its margins.</li><li>Price target remains at the Street-low $11.</li><li>Flex shares are <font color=\"green\">up 4.9% </font>pre-market to $9.81.</li><li>Flex has an Outperform <a href=\"https://seekingalpha.com/symbol/FLEX/ratings/sell-side-ratings?s=flex\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469481\" data-linked=\"Flex +5% on Goldman Conviction List addition\" data-tweet=\"$FLEX - Flex +5% on Goldman Conviction List addition https://seekingalpha.com/news/3469481-flexplus-5-on-goldman-conviction-list-addition?source=tweet\" data-url=\"https://seekingalpha.com/news/3469481-flexplus-5-on-goldman-conviction-list-addition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469477\" data-ts=\"1559822466\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JE\" target=\"_blank\">JE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469477-just-energy-launches-strategic-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Just Energy launches strategic review</a></h4><ul><li>Just Energy (NYSE:<a href='https://seekingalpha.com/symbol/JE' title='Just Energy Group Inc.'>JE</a>) <font color=\"green\">+5.7%</font> pre-market after announcing a <a href=\"https://seekingalpha.com/pr/17536476-just-energy-group-inc-announces-strategic-review-process\" target=\"_blank\">review of its strategic alternatives</a> and saying it  received expressions of interest from groups about potential transactions.</li><li>JE says its board has appointed a committee comprised of all of the independent directors to oversee the process.</li><li>The company says it has not established a definitive timeline to complete the review.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469477\" data-linked=\"Just Energy launches strategic review\" data-tweet=\"$JE - Just Energy launches strategic review https://seekingalpha.com/news/3469477-just-energy-launches-strategic-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3469477-just-energy-launches-strategic-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3469473\" data-ts=\"1559821871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLDR\" target=\"_blank\">CLDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3469473-cloudera-q1-was-thesis-changer-needham\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cloudera Q1 was a &#39;thesis changer&#39;- Needham</a></h4><ul><li>Needham downgrades Cloudera (NYSE:<a href='https://seekingalpha.com/symbol/CLDR' title='Cloudera, Inc.'>CLDR</a>) from Strong Buy to Hold after yesterday's earnings print.</li><li>The firm sees Q1 as a true thesis changer due to the lack of clarity on the new Cloudera Data Platform launch, an alarming uptick in customer churn, and the resignation of CEO Tom Reilly.</li><li>At best, Needham thinks it will take several quarters for Cloudera to rebuild credibility and for the Data Platform's financial impact to be evident.</li><li>Cloudera <a href=\"https://seekingalpha.com/news/3469372-cloudera-minus-27-percent-downside-outlook-ceo-resignation\" target=\"_blank\">reported</a> Q1 beats and downside revenue outlook for both Q2 and FY20.</li><li>CLDR shares are <font color=\"red\">down 36%</font> pre-market to $5.62.</li><li>Cloudera has a Very Bearish <a href=\"https://seekingalpha.com/symbol/CLDR/ratings/quant-ratings\" target=\"_blank\">Quant rating</a> and an Outperform <a href=\"https://seekingalpha.com/symbol/CLDR/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3469473\" data-linked=\"Cloudera Q1 was a &#39;thesis changer&#39;- Needham\" data-tweet=\"$CLDR - Cloudera Q1 was a &#39;thesis changer&#39;- Needham https://seekingalpha.com/news/3469473-cloudera-q1-was-thesis-changer-needham?source=tweet\" data-url=\"https://seekingalpha.com/news/3469473-cloudera-q1-was-thesis-changer-needham\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}